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ABSTRACT 	
 
 
 
Evaluation of the Pilot Program, Pediatric Early Warning Sentinel Surveillance 
Program (PEWSS), and its Efficacy in Monitoring Pediatric Illness in Clark 
County, Nevada. 
 
By 
Michelle Lutman 
 
 
Dr. Mark Buttner, Committee Chair 
Associate Professor 
University of Nevada, Las Vegas 
 
 
 
The influenza outbreak that occurred during 2009 stimulated the formation of 
several surveillance programs throughout the country.  The majority monitor only 
influenza; however, there are several other circulating respiratory pathogens, especially 
within the pediatric community.  These other respiratory pathogens cause a variety of 
illnesses, such as bronchitis, pneumonia, croup, etc.  Prior research has provided the 
medical community with valuable information about respiratory illnesses, especially 
those which afflict pediatric patients.  Areas of knowledge including seasonality, 
demographics, signs and symptoms, prevention measures, and pathogenicity, have been 
greatly expanded over the years.  This information has been of tremendous help to the 
medical community in identifying respiratory illness. Coupled with surveillance, this can 
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further help to expand the knowledge of illnesses that are circulating, especially for local 
public health communities. 
In May 2009, the Southern Nevada Health District (SNHD) and the Southern 
Nevada Public Health Laboratory (SNPHL) collaborated to create a new pilot 
surveillance program, the Enhanced Pediatric Influenza Surveillance project (EPIS).  It 
began like most others and monitored only influenza.  Evolution of the program took 
place and ultimately developed into a more enhanced monitoring program, the Pediatric 
Early Warning Sentinel Surveillance program (PEWSS).  This became a one of a kind 
program that went above and beyond traditional surveillance, to include more than just 
the reportable respiratory pathogens.  The objective of the PEWSS program is to relay the 
knowledge of circulating viruses to the community to increase public health awareness 
and prevention, along with developing seasonal baselines for each virus. 
Once a public health program is in place, an evaluation should be conducted to 
determine the efficacy and usefulness of the system.  Evaluations can help streamline the 
goals and objectives, along with improving the manner in which the program operates.  In 
July 2001, the CDC published guidelines that are used as the basis to evaluate any public 
health surveillance system. These CDC guidelines were the foundation for the evaluation 
of the PEWSS program.   
The goal of this project was to evaluate the efficiency and effectiveness of the 
PEWSS program by determining the strengths and weaknesses of the program. In 
addition, an analysis of the data already collected by the EPIS and PEWSS programs was 
performed.  The PEWSS data were compared to similar local and national data sources. 
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Comparison of data between the PEWSS program and the outside sources showed similar 
seasons among the different respiratory pathogens, which substantiated the effectiveness 
of the program. The conclusion of the evaluation and data analysis showed that the 
PEWSS program is an efficient and effective system that can monitor respiratory illness, 
and trends, and also provide pertinent circulating respiratory pathogen information to the 
community.  
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CHAPTER 	1 	 ‐ 	INTRODUCTION 	
 
Respiratory illness is listed as the second leading cause of death worldwide in 
children less than 5 years old.32  Respiratory viruses are of high importance due to the direct 
and/or indirect transmission throughout the community.  Younger children have a less 
developed immune system than adults, which makes them a more susceptible population to 
respiratory viruses.  These pathogens are easily spread by person-to-person contact, droplets 
in the air, and inanimate objects, causing a variety of illnesses.6 For instance, respiratory 
syncytial virus (RSV) is the main cause of bronchiolitis and pneumonia in children less than 
1 year of age.6  In cases of acute bronchitis, RSV was 2 times more likely to be the culprit 
rather than influenza.12  Overall, it is believed that RSV causes more illnesses in pediatrics 
than influenza.12  RSV hospitalizes around 75,000 to 125,000 children each year.6 Human 
parainfluenza virus (HPIV) causes tracheobronchitis and pharyngitis in children 1 to 4 years 
old, and can cause pneumonia, bronchitis, or croup.6  HPIV is responsible for a wide range, 
1,800 to 52,000, of annual hospitalizations in the United States.32 Adenovirus can cause 
illnesses that mimic the common cold and pneumonia, but also cause croup and bronchitis.6 
Human metapnuemovirus (HMPV), discovered in 2001, is nearly identical to RSV and can 
cause a range of illnesses such as laryngitis, bronchitis, pneumonia or asthma.6,32    
In 2008, according to the National Ambulatory Medical Care Survey, diseases of the 
respiratory system were responsible for 10% of the overall primary diagnoses, which fell 
second to preventative and follow-up care visits at 20.9%.26  Outpatient primary diagnosis 
visits had similar findings of 10.9% for diseases of the respiratory system and 18.8% for 
preventive and follow-up care.26  In 2008, the highest visited physician specialty was for 
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pediatrics, which generated 175.1 visits per 100 persons per year, with general and family 
practice at 75.1 visits per 100 persons per year.26  During 2009, three quarters of the children 
in the United States of America had seen a physician at least once within 6 months, 
according to the Summary Health Statistics for U.S. Children.2  Three quarters of the 
children utilized a doctor’s office for their usual place of health care and another 24% used 
clinics as their usual place of care.2  More children have a usual place of health care, at 
95.2%, compared to adults, aged 18 and older, at 83.2%.2,24  In 2008, 91.5% of children, 
under 18 years of age, had a visit with a doctor, compared to 82.5% of adults. 2,24  Realizing 
that children are more likely to visit their physician earlier than an adult, this can be 
monitored, providing earlier indicators of circulating disease.   
The influenza outbreak of 2009 created controversy reaching every part of the globe.  
Influenza was the known source, however, the strain that caused the epidemic was a mystery.  
As estimated by the Centers for Disease Control and Prevention (CDC), for the general 
population, there were over 12,000 deaths, 274,000 hospitalizations and over 60 million 
cases.5  For the pediatric group, there were over 1,000 deaths, 86,000 hospitalizations and 19 
million cases.5  This wide spread pathogen demonstrated the need to expand techniques in 
existing surveillance systems and generate new programs.   
To understand which strains are circulating within a community, surveillance needs to 
be conducted and has become rapidly popular since the 2009 H1N1 scare.  Several agencies 
around the country track respiratory illnesses, such as influenza, utilizing different 
methodologies of surveillance to capture data. These systems gather information in several 
ways, such as collecting information from laboratories or hospitals, phone calls, health 
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surveys, databases, etc.  The data are gathered, disseminated, and distributed among the 
public. Active surveillance systems have begun throughout the country monitoring influenza, 
including the CDC, which has a dedicated site for influenza.7 However, influenza is not the 
only respiratory illness that circulates within a community, particularly the pediatric 
community. The other website developed by the CDC is the National Respiratory and Enteric 
Virus Surveillance System (NREVSS), which tracks other viruses such as respiratory 
syncytial virus (RSV), adenovirus, and human parainfluenza virus (HPIV).6  These viruses 
are of high importance in the community due to the direct and/or indirect transmission 
throughout the community.   
Other states and counties have developed their own methods of surveillance, 
dissemination of the data and reporting for relaying their findings to the public.  The majority 
of the reports examined were lacking a variety of information.  A selection of reports only 
contained information on influenza and rarely any of the other respiratory pathogens.  Most 
of the reports reiterated CDC findings of influenza for a specific location and also used only 
information and/or charts provided by the CDC website.  A few of the surveillance programs 
monitored only during the “flu season” (i.e. influenza was only monitored during the time 
frame it normally occurs).  A foreseeable problem with that kind of surveillance is that these 
respiratory viruses can occur at any point throughout the year and any abnormal spike or 
outbreak would be missed.  Charts provided on some of the reports were not complete or 
they were difficult to decipher (i.e. multiple years on one chart).  Pediatric data were not 
separated from adult data in reports.  If pediatric information was separated, the data or 
charts were difficult to understand.  Some included pediatrics to age 13 and some to only age 
5. Also not seen, were the ages within the pediatric population being most afflicted by these 
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pathogenic viruses.  Some of the reports were too lengthy; one was found to be 13 pages 
long.  Some locations chose only to report on hospitalized or emergency room data for the 
population.  This provides a biased idea of the activity, because those are the extremely sick 
of the population.  There are several surveillance programs that report rare illness or injury 
that occur within a population.  This is very useful for research or to create policy change if 
needed, but it does not help with information about commonly circulating illnesses that could 
affect every person at some point in their life.  While it is very important that surveillance be 
conducted to inform the public of circulating viruses, what is lacking is the specific 
knowledge of the different respiratory activity within a community, such as seasonal 
respiratory trends or incidence within a particular age group. 
In Clark County, located in southern Nevada, there was no surveillance program 
developed for the public to understand which pediatric respiratory viruses were circulating at 
any time during the year.  This led the Southern Nevada Health District and the Southern 
Nevada Public Health Laboratory to realize the need for a program that would monitor 
influenza H1N1 among their pediatric patients. In May of 2009, the Southern Nevada Health 
District (SNHD) and the Southern Nevada Public Health Laboratory (SNPHL) collaborated 
to develop a pilot surveillance program titled Enhanced Pediatric Influenza Surveillance 
(EPIS) project.  The objective of the program was to monitor influenza within the pediatric 
community, which is a reportable disease to the SNHD.  The information and experience 
gained from the generation of the EPIS program led to the idea to further expand the program 
to include other circulating respiratory illnesses in the pediatric community.  The Pediatric 
Early Warning Sentinel Surveillance program (PEWSS) was developed in May 2010, and is 
the current expansion of the EPIS program.   Going beyond influenza A and B, the PEWSS 
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program also monitors respiratory syncytial virus (RSV), human parainfluenza virus 1/2/3 
(HPIV), and adenovirus along with the more recent pathogen, human metapneumovirus 
(HMPV).  Since influenza and RSV are the only two reportable viruses, listed within the 
pathogens monitored by the PEWSS program, in Clark County, Nevada, the community is 
not aware of other circulating respiratory pathogens or the seasonality in which they occur.  
The objective of this program is to use sentinel surveillance to relay the knowledge of these 
particular viruses to the community to increase public health awareness and prevention along 
with developing seasonal baselines for each virus. 
Sentinel surveillance is a good method for monitoring respiratory pathogens that are 
not mandated as reportable events,4 making this form of surveillance ideal for the PEWSS 
program. Because virus identification is not necessary for initial treatment of the child, it   
does not delay treatment.   Data collection for the PEWSS program occurs throughout the 
year, since these viruses occur at various times throughout the year.   Sentinel surveillance is 
usually conducted by gathering information from different providers.  The SNHD and the 
SNPHL have taken on the responsibility of all the testing and transportation for the multiple 
sites to minimize errors and keep consistency in the testing.  Conducting surveillance by the 
way of sentinel sites does have advantages, but also has disadvantages as well.  When 
sentinel surveillance is performed, it is important to remember that the results are not 
representative of the entire population and sampling bias can exist.4  However, using sentinel 
surveillance gives greater design flexibility, uses fewer resources than other systems, and 
being more personable, can strengthen and build new relationships within the community.4   
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Once a public health program is in place, an evaluation should be conducted to 
determine the efficacy and usefulness of the system.  Evaluations are an important part of a 
public health program; they can help streamline the goals and objectives, along with 
improving the manner in which it operates.14  The CDC states that the purpose of evaluating 
public health surveillance systems is to ensure that problems of public health importance are 
being monitored efficiently and effectively.14   In September 1999, through the Morbidity 
and Mortality Weekly Report (MMWR), the CDC published their first guidelines entitled 
“Framework for program evaluation”.19 An updated version was provided in July 2001, titled 
“Updated guidelines for evaluating public health surveillance systems.”14 There have been 
different program evaluation guidelines published, but none as useful, in depth or easy to 
follow as the guidelines provided by the CDC.  These guidelines provide the basis for 
performing an evaluation for any public health program. To evaluate the efficacy of the EPIS 
and PEWSS program, the CDC Updated Guidelines for Evaluating Public Health 
Surveillance Systems were applied.   
For this study, there are three main objectives. The first objective is to perform a 
program evaluation on the PEWSS program, as described by the tasks listed by the CDC 
guidelines. This will evaluate the efficiency and effectiveness of the PEWSS program by 
determining the strengths and weaknesses of the program.   The second objective is to 
analyze and disseminate the data gathered by the PEWSS and EPIS programs, for each virus, 
to discover the demographics and trends since the inception of the programs. The third 
objective is to determine, by comparison with similar outside data, if the PEWSS program is 
accurately capturing the different seasonal trends for the different respiratory pathogens. The 
goal of this study is to determine whether the PEWSS program is an effective and efficient 
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program that can successfully monitor pediatric respiratory viruses along with relaying this 
pertinent pediatric respiratory pathogen information to the community.  
CHAPTER	2	‐ 	METHODS	
DATA	COLLECTION	
PROGRAM	OPERATION	
 
The viruses under surveillance in the PEWSS program are influenza A (with subtypes 
H1, H1N1 and H3) and B, respiratory syncytial virus (RSV), adenovirus, human 
parainfluenza virus 1, 2 and 3 (HPIV) and human metapneumovirus (HMPV).  
Sentinel sites were selected based on their willingness to participate in the program, 
the volume of patients and by the mix of financial status of their patients.1 The practicing 
physicians are involved in the program on a voluntary basis and allowed to opt out at any 
time.1  
The current case definition used by all pediatricians is universal for all of the 
respiratory pathogens monitored.  The case definition is any child aged 17 years or less and 
that present with a fever >100°F along with a cough and/or sore throat, which is also known 
as influenza-like illness (ILI). 
The SNPHL provides the sites with materials required for collection (described 
below) and also training for the collection of samples. The pediatrician’s offices then collect 
and submit the first ten specimens each week from pediatrics fitting the case definition.  
Depending on the severity of the circulating pathogens, a maximum of 50 samples, 10 per 
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site, can be collected per week.  Samples are transported three times a week by SNPHL 
couriers.  The specimen kits are replenished once a week by the couriers to ensure that each 
site does not receive more than 10 kits each week.   “The SNPHL performs full respiratory 
panels, APHL real time RT-PCR Assays for Respiratory Virus Pathogens, the CDC Human 
Influenza Virus Real-time RT-PCR Detection and Characterization Panel, along with the 
CDC Influenza 2009 A (H1N1) pdm Real-Time RT-PCR Panel.”1   There is no charge to the 
physicians for sample collection and testing performed for the PEWSS program.  The 
PEWSS physicians agreed that neither the patient nor the patient’s insurance would be 
charged for respiratory surveillance testing performed by SNPHL. 
Once testing is complete, each site receives a written report for each sample analyzed.  
The SNPHL also prepares a summary with all panel results, which contains de-identified 
results, on a commonly shared spreadsheet for use by the SNHD Office of Epidemiology.  
The SNHD Office of Epidemiology prepares a weekly report based on the laboratory 
findings from the previous week.  These reports give a brief description of the current 
circulating pathogens, along with detailed charts and graphs that give a breakdown of the 
pathogens.  The reports are distributed weekly to local healthcare providers by e-mail or fax 
and can also be found on the SNHD website.  
SAMPLE	COLLECTION1	
 
Sample collection, sample analysis, and influenza viral resistance and surveillance 
testing sections were previously established methods for laboratory protocols.  “The choice 
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of sample type to utilize for the PEWSS program at the SNPHL was based on multiple 
factors including: 
 Ease of collection 
 Minimal training for staff 
 Minimal trauma to patient 
 Minimal equipment 
 Minimal collection time 
 Approved for use with test method 
 Acceptable sample yield for surveillance testing 
 Minimal cost” 
 
“Acceptable sample types for use with the molecular Influenza and non-influenza 
respiratory virus panel performed at SNPHL included nasopharyngeal or nasal swabs.  
Previous studies had identified that nasal swab collection samples were comparable to 
nasopharyngeal swab samples when tested by molecular methods.16 Due to the ease of 
collection, minimal cost, and comparability with nasopharyngeal swabs, the nasal swab was 
identified as the sample type of choice for use in the PEWSS program.  During initial 
PEWSS site visits, clinic staff was instructed on proper nasal swab collection technique.” 
“Various studies29,9 have indicated that the use of a nylon flocked nasal swab 
provides greater yield of epithelial cells for viral testing.  The flocked swab lacks the internal 
mattress core present in traditional fiber wound swabs.8  This lack of an internal mattress 
core allows the sample to stay close to the surface rather than be absorbed into the interior.8  
“The perpendicular nylon fibers act like a soft brush and allow for improved collection of 
cell samples.”8  Because the sample stays close to the surface it is easily released when the 
flocked swab is mixed with viral transport medium.”8 
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“To ensure that the recommended flocked swab was used for sample collection, 
SNPHL provided standardized sample collection kits to each of the PEWSS sites.  The kits 
included a flocked nasal swab, viral transport media (VTM) and a SNPHL test requisition 
packaged in an individual sample collection bag.  The collection kits were stored at 
refrigerated temperature until sample collection was performed.  Following sample 
collection, the flocked swab was placed in the VTM and mixed.  The entire sample was 
returned to refrigerated storage until pickup by the SNPHL courier.” 
 
SAMPLE	ANALYSIS1	
 
“After receipt at SNPHL, each sample VTM was extracted on the Roche Compact 
analyzer (Roche, Indianapolis, IN) utilizing the Roche MagNA Pure Compact Total Nucleic 
Acid Isolation Kit 1 with external lysis.” 
“Each extracted nucleic acid sample was analyzed on the Applied Biosystems 7500  
Fast DX (Applied Biosystems, Carlsbad, CA) platform using the following real time reverse 
transcriptase polymerase chain reaction (rRT-PCR) protocols: 
  
Centers for Disease Control and Prevention (CDC) Human Influenza Virus Real-time 
RT-PCR Detection and Characterization Panel (Influenza A, Influenza A/H1, 
Influenza A/H3, Influenza B) In-vitro Diagnostic (IVD) use – FDA approved 
 
CDC Influenza 2009 A (H1N1) pdm Real-Time RT-PCR Panel In-vitro Diagnostic 
(IVD) use – FDA approved 
 
Association of Public Health Laboratories (APHL) real time RT-PCR Assays for 
Respiratory Virus Pathogens (Human Metapneumovirus, Adenovirus, Respiratory 
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Syncytial Virus, Parainfluenza 1,2,3) Laboratory Developed Test – validated by 
SNPHL” 
 
INFLUENZA	VIRAL	RESISTANCE	AND	SURVEILLANCE	TESTING1	
 
“As a recipient of the CDC influenza surveillance testing reagent kits, CDC requested 
that SNPHL, routinely, submit up to 5 influenza positive samples collected through the 
respiratory surveillance program to an assigned virus isolation laboratory.  Depending on the 
level of influenza activity, the samples were submitted either weekly or biweekly.”   
“The SNPHL propagated large quantities of influenza virus from the submitted 
samples which were then sent to CDC for additional antigenic characterization.  The testing 
performed at CDC included antigenic characterization, genetic analysis (sequencing) and 
tests for sensitivity to FDA-approved drugs.  The information from the additional testing 
provided CDC and the World Health Organization (WHO) with valuable data which were 
used to identify the influenza strains to be used in the 2011-2012 influenza vaccine. The 
results of this testing performed at CDC were for epidemiological purposes only.  If SNPHL 
received results of the additional CDC testing, it was not reported back to the submitting 
physician.   At the initial program site visit, the physicians were notified that additional 
testing could be performed at CDC and that they would not receive a written report of the 
additional testing.” 
“Additional testing for Influenza A H1N1 viral resistance was performed by regional 
contract laboratories.  Up to 5 PEWSS surveillance samples that were Influenza A H1N1 
positive were submitted either weekly or biweekly by SNPHL to the assigned laboratory.  
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The regional laboratory performed pyrosequencing to identify oseltamivir resistance in 
influenza A H1N1 viruses caused by H275Y mutation in the neuraminidase.”     
“Chapter 3 of the Regulations Governing the Reporting of Diseases, Exposures, and 
Sentinel Health Events27, along with the Nevada Administrative Code (NAC) 441A20, 
provide the necessary authorities for investigation of events or outbreaks of public health 
significance and to request cooperation from other persons or medical laboratories in the 
investigation and suppression of disease.”   
METHODS	FOR	TASKS	IN	THE	CDC	GUIDELINES	FOR	EVALUATING	PUBLIC	
HEALTH	SURVEILLANCE	SYSTEMS	
 
This evaluation used the CDC Updated Guidelines for Evaluating Public Health 
Surveillance Systems published in the Morbidity and Mortality Weekly Report (MMWR) in 
July 2001.14  The guidelines outlined each task and the components required to fulfill each 
task.  There are 6 total tasks listed in the guidelines as Tasks A-F.  Not all of the tasks will 
have a method component, this is because various portions are descriptive only.  
Nevertheless, components of each task can be seen in the CDC’s check list (Appendix A), 
along with the detailed sections for each task (Appendix B).  
The Institutional review board (IRB) at University of Nevada, Las Vegas (UNLV) 
gave approval to conduct this project as exempt on February 28th, 2011 (Appendix C). 
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TASK	A	‐	ENGAGE	THE	STAKEHOLDERS	IN	THE	EVALUATION	
 
Task A was comprised of defining who the stakeholders are for this evaluation and 
gathering their input about the program.  The stakeholders in this evaluation are those that 
receive the weekly information and/or those that provide the data, which consist of all health 
professionals within the medical field, scientific community, the general public, and the 
sentinel sites which provide the samples that provide the data used to generate the reports.  
The manner in which the data are being used and by whom was investigated using two 
methods, interviews of people who receive the data and surveys that were distributed among 
the various stakeholders.   
It is important to understand the self-selection bias utilizing these surveys.  Two 
surveys were administered, one for the users of the PEWSS bulletins (public surveys 
described below) and the other for the sentinel sites that provide the data (sentinel site 
survey) (Appendices D and E).  The first survey (Appendix D), was sent only to those who 
receive the weekly bulletin via e-mail or fax and was completed only on a voluntary basis.  
Targeted were those that received and read the bulletin, and also had the time and willingness 
to complete the survey.  The sentinel site survey (Appendix E), was only sent to the 
individual sites to be completed by different personnel.  The nature of selecting specific 
groups of people to complete these surveys and giving them the option to respond, generated 
the self-selection bias. 
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INTERVIEWS	
 
Interviews were held regarding the information contained in the PEWSS bulletins.  
Interviews included staff members in the SNHD Office of Epidemiology with other health 
care professionals, such as laboratory manager and public health officers.   
PUBLIC	SURVEY	
 
Survey Monkey, an internet-based electronic survey tool, was used to create a survey 
to gather feedback of the stakeholders for those who read and use the information generated 
by the PEWSS program.  A survey was formulated on the Survey Monkey website, with a 
trial survey administered within the SNHD Office of Epidemiology, for feedback and 
accuracy (Appendix D). The survey was then given to the stakeholders in the form of e-mail 
and fax when they received a weekly bulletin.  A link was contained in the fax or e-mail to 
allow them to voluntarily participate in the survey.   A time frame of two weeks was given to 
complete the survey.   
SENTINEL	SITE	SURVEY		
 
A separate survey, created by the SNPHL, was administered only to the staff at the 
five participating sentinel sites (Appendix E).   Helping to build and strengthen the 
relationship between the personnel at the sites and the SNHD, one person from each office, 
Office of Epidemiology and the SNPHL, visited each of the five sentinel sites to administer 
the survey.  The office personnel were given the surveys and asked to return it, by fax or 
courier, to the SNPHL.   
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TASK	B	–	DESCRIBE	THE	SURVEILLANCE	SYSTEM	TO	BE	EVALUATED	
 
Task B involved 3 separate components.  Section B1 was to describe the significance 
of the public health event under surveillance in the program.  Section B2 listed the details of 
the program, to include purpose, objectives, case definition and components of the program.  
Lastly, section B3 listed the funding sources and cost analysis, which were utilized to run the 
program.  This cost analysis to included the cost of the system for the SNHD, Office of 
Epidemiology and the SNPHL.  For the SNHD, the analysis consisted of the manpower used 
for the start-up of the program, which included the estimated time it took to develop the 
customized spreadsheets, estimated time it took to decipher how to organize and disseminate 
the data and who was going to be responsible for certain duties.  The other analysis was for 
the average ongoing maintenance needed for the year. The cost analysis does not include the 
monetary value of computers, software, printers, phones, fax, etc.  It is assumed that the 
office has already been established, implying the basic office items are already in place.  
These would not be considered as additional resources needed for the program.  The only 
cost is for the personnel to conduct the analysis for the program itself. 
Before implementing the laboratory portion of the EPIS program, time was reserved 
to develop the details to plan the EPIS program, write the project description, validate test 
methods, and also to create the kits and paperwork supplied to each site.  Lastly, time was 
also devoted to selecting the sites and conduct specimen collection training at each location. 
The laboratory cost analysis consisted of 3 different elements. Two parts of the cost analysis 
are similar to the cost analysis of the Office of Epidemiology, a startup personnel cost and an 
ongoing  maintenance personnel cost.  The third part involved the cost of laboratory supplies. 
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To calculate the cost for startup and yearly maintenance for the laboratory, information was 
required from the laboratory, such as the amount of time the laboratory personnel utilized to 
setup the program, the amount of time per week they spend processing samples, and the 
amount of time for couriers to transport specimens. 
TASK	C	–	FOCUS	THE	EVALUATION	DESIGN	
 
Task C involved streamlining the evaluation to certify that time and resources were 
used as effectively as possible.14  Topics for this task were to identify the stakeholders, 
previously defined in Task A, determine the specific purpose of the evaluation, contemplate 
what will be done with the findings of the evaluation, indicate questions that will be 
answered by the evaluation, and ascertain the standards for assessing the program 
performance. 
To determine the standards for assessing the performance of the PEWSS program, a 
literature review was conducted to find similar programs. 23,28,32   
TASK	D	–	GATHER	CREDIBLE	EVIDENCE	
 
The first segment of Task D required the system to answer at least 1 of the following 
6 questions.14 Does the system: 
1. Detect diseases of public importance in a timely way to permit accurate diagnosis or 
identification, prevention or treatment, and handling of contacts when appropriate? 
2. Detect trends that signal changes in the occurrence of disease, injury or adverse or 
protective exposure, including detection of epidemics (or outbreaks)? 
3. Lead to improved clinical, behavioral, social, policy, or environmental practices? 
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4. Provide estimates of the magnitude of morbidity and mortality related to the health 
related event under surveillance, including the identification of factors associated 
with the event? 
5. Permit assessment of the effect of prevention and control programs? 
6. Stimulate research intended to lead to prevention or control? 
 
Gathering evidence involved a second segment of Task D, which entailed the 9 
components of evidence used to evaluate the system.14 Ratings for the components were 
either high, medium, low or not applicable (N/A). 
1. Simplicity – The structure and ease of the program operation14 
2. Flexibility – How the program will adapt to any form of change14 
3. Data quality – Completeness and validity of the data14 
4. Acceptability – How willing are the contributors engaged in the program? 14 
5. Positive Predictive Value (PVP) – Can the system measure the proportion of reported 
cases that are true positives using calculated numbers from the true positives and the 
false positives? 14 
6. Sensitivity – Can the system detect outbreaks and monitor changes in the amount of 
cases over time or can it be measured using the true positives and the false negatives? 
14 
7. Representativeness – Can the system accurately portray the health event under 
surveillance and the distribution by place and person? 14 
8. Timeliness – How long does it take between each step in the process of the program? 
14 
9. Stability – Is the method of collection of data a reliable system and are the machinery 
used to run the program stable? 14 
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TASK	E	–	JUSTIFY	AND	STATE	CONCLUSIONS,	AND	MAKE	RECOMMENDATIONS	
	
Task	E	involved	gathering	all	of	the	evidence	and	analyzing	and	interpreting	the	
findings,		also	including	the	stakeholder’s	opinions	and	how	they	will	be	using	the	findings.		This	
portion	will	also	include	analysis	on	whether	or	not	the	program	is	meeting	its	objectives	and	
properly	addressing	the	public	health	problem.			Recommendations	will	also	be	made	to	try	and	
strengthen	those	attributes	that	are	weak	without	adversely	affecting	the	others.			
TASK	F	–	ENSURE	USE	OF	EVALUATION	FINDINGS	AND	SHARE	LESSONS	LEARNED	
	
The	findings	of	the	evaluation	will	be	discussed	with	the	staff	involved	with	the	program	
to	determine	the	best	course	of	action	to	disseminate	the	conclusion	to	the	appropriate	people.	
METHODS	FOR	THE	ANALYSIS	OF	THE	DATA	FOR	THE	PEWSS	PROGRAM	
 
Data gathered by the expanded PEWSS program were analyzed for descriptive 
information. Data of the same time period and viruses were requested from the CDC’s 
division of the National Respiratory and Enteric Virus Surveillance system (NREVSS).  Also 
requested, were similar data from the hospital located at Nellis Air Force Base, the Mike 
O'Callaghan Federal Hospital, which is located in Clark County, Nevada, for local 
comparison.  These data were charted in Microsoft Excel and compared visually for common 
seasonality and trends for all 3 data sets. 
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CHAPTER	3	‐	RESULTS	OF	THE	CDC	EVALUATION		
TASK	A	‐	ENGAGE	THE	STAKEHOLDERS	IN	THE	EVALUATION	
INTERVIEWS	
 
The responses to the bulletin, via interviews, were well received with high regard for 
the program. Negative responses about the program were not reported.  Some of the 
responses included, “I look forward to the bulletins each week” and “I forward the bulletins 
to all of my employees in the laboratory, so they are kept up to date with the pathogens.”  
PUBLIC	SURVEY	
 
Nineteen total responses to the public surveywere received and analyzed (Appendix 
D). There were a variety of professions that responded to the survey, including physicians, 
nurses, laboratory staff, educators, administration staff and day care providers.  The 
stakeholders were located in different areas of practice settings, such as hospitals, clinics, 
private offices, and small and large group practices.  The majority, 89.5% (n=17), of the 
stakeholders responded that they have read the PEWSS bulletins (Appendix F), and 64.7% 
(n=11) responded that they read the bulletin at least every week, and 29.4% read it 
frequently, but not every week.  The information within the PEWSS bulletin was rated high, 
by greater than 80% of the respondents, in the categories of timely, accurate, relevant and 
useful.  The survey addressed how the stakeholders use the bulletin information. Responses 
varied for all of the categories, except for general information, which was answered by 100% 
of the respondents.  The majority of respondents (n=12), occasionally or never use the 
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information to guide clinical diagnosis, 52.9% (n=9) never use the information to guide 
empirical treatment, and 64.7% (n=11) never use it to guide laboratory testing.  Because not 
all of the respondents were physicians for this survey, higher ratings than expected were seen 
for “never” were seen when asked how they use the bulletin information. When asked what 
they felt was the most useful about the bulletin, nine of the respondents were in favor of 
knowing the current weekly rates of the pathogens which kept them up to date on what is 
circulating in the community and what to look for.  The least useful information determined 
by the stakeholders, were the age distribution graphs and the weekly positive graphs for each 
pathogen.  As optional questions, the stakeholders were also asked for any improvements that 
would make for a better bulletin.  Ten individuals responded with suggestions. Four liked the 
current state of the bulletin.  The others suggested changes; adding more sentinel sites, 
changing the graphs, adding national data or more technical information regarding the 
pathogens. Changes were made to the PEWSS bulletin to accommodate the suggestions 
(Appendix G). Some of the changes suggested by the stakeholders: age graphs were 
eliminated, the general update section was shortened. Figure 1 of weekly number of 
specimens tested added negative to the positive rates. Figure 2 for the weekly positive counts 
was changed to bar graphs and Table 1, testing results, added an interpretation for the 
pathogenic activity for the week to show level of activity.  
SENTINEL	SITE	SURVEY	
 
Among the 5 sentinel sites, there were 19 responses received and transposed into 
Survey Monkey to analyze the results (Appendix E). Most respondents were physicians at 
42% (n=8).  The majority of the respondents had a very favorable response towards the 
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PEWSS program.  Almost all agreed, or strongly agreed, to all of the first part of the survey, 
which addressed: prompt responses by SNPHL and the SNHD, easy to complete test 
requisition forms, having couriers automatically pick up specimens was easier than phone 
calls, patient reports and the PEWSS bulletin were easy to understand, they felt competent in 
collecting the specimens, and they would recommend their colleagues to partner with the 
SNPHL and the SNHD.  The sites primarily received their PEWSS bulletins by fax and email 
directly from the SNHD, with 44% (n=8) reading them every week and 22% (n=4) reading it 
frequently but not every week.  78% (n=14) of the respondents use the PEWSS bulletins for 
general information, and 44% (n=8) use the information to guide their clinical diagnoses.  
Almost all of the respondents thought the information in the PEWSS bulletins were timely, 
accurate, relevant to them, useful, and easy to read and understand.  Only 1 person responded 
the information was not relevant to them.  This survey also revealed that most of the people 
collecting the PEWSS specimens were the physician, nurse or medical assistant.  Wellness 
checkups were at least 40% or greater of their regular patient visits.  Also asked in the survey 
was what they believed to be most useful about the bulletins.  There were a few respondents 
that use the bulletins to show their patients what is circulating in the community, and to 
reinforce the idea of not using antibiotics when the cause is viral in nature.  When asked what 
they liked least, a few had responded the reports were too long and there was a need for 
better graphs.   
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TASK	B	‐	DESCRIBE	THE	SURVEILLANCE	SYSTEM	TO	BE	EVALUATED	
TASK	B1	
 
 
Task B1 involved describing the public health importance of the event that is under 
surveillance. Under examination by the PEWSS program are the respiratory pathogens that 
continue to circulate.  The importance of respiratory pathogens in the community are the 
illnesses that are produced by them and the ease of transmission among the pediatric 
population.  The introduction portion of this evaluation explored the importance of these 
public health events in greater detail. 
TASK	B2		
 
Task B2 involved describing the purpose and operation of the surveillance system 
being evaluated.  Most sections of this task have been described in greater detail in earlier 
sections of this evaluation. Therefore, for this portion of the task, the sections below will 
contain brief descriptions. A logic model1 was created explaining the series of tasks of the 
program (Appendix H). 
PURPOSE	
 
The purpose of the PEWSS program is to compile and track laboratory based data 
into reports that will inform the community of the circulating seasonal respiratory pathogens 
in pediatrics year round. 
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OBJECTIVES	
 
The objectives of the PEWSS program are to monitor and track respiratory viruses, 
develop seasonal trends and a baseline for Clark County, monitor co-infections, provide 
weekly reports to inform public, provide early warning of increased activities, and strengthen 
relationships with the local medical community. 
PLANNED	USE	
 
The PEWSS program will help inform doctors as to which viruses are circulating to 
help streamline testing and to inform the public what the SNHD is seeing in the pediatric 
population of Clark County, Nevada.  
COMPONENTS	OF	THE	SURVEILLANCE	SYSTEM	
 
Population 
The sick, parental care seeking, pediatric population of Clark County, Nevada 
 
Period of time collected 
The data are collected year round from participating pediatricians’ offices 
 
What data are collected and how 
The samples are provided by the sentinel sites.  Samples consisting of a 
nasopharyngeal swab from the child are provided by the sentinel sites.  Once collected, a 
courier from the SNHD will pick up samples three times a week and deliver them to the 
SNHD laboratory.  Once the respiratory panels are performed, the results are relayed back to 
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the physician.  The de-identified results of the respiratory panel are then compiled into a 
spreadsheet, along with age, gender, date of birth, CDC week and collection date, for the 
SNHD Office of Epidemiology to analyze.   
 
Reporting sources for data 
The data are derived from the samples submitted by the sentinel sites.  Data for the 
PEWSS program bulletins are obtained from the SNPHL common shared Excel spreadsheet. 
 
How the system is managed 
The entry of the laboratory confirmed panel results is done by the laboratory 
personnel.   The data are stored on encrypted servers located at the SNHD, which are backed 
up multiple times a day onsite and offsite.  The computers that have access to the information 
are password protected.  If panel results are positive, the pathogen is specified.  To identify 
the virus, the spreadsheet is setup to allow a pull down menu that allows specific entries into 
the cells for the panel results, to help keep consistency among the data.  The other data 
entered are age, collection data, and CDC week.  The data are used in house for 
informational purposes only, and are not distributed publicly. 
 
How the data are analyzed 
The data are analyzed once a week by the personnel at the SNHD, Office of 
Epidemiology.  The results are reformatted and placed into a customized Microsoft Excel 
spreadsheet to create the bulletin by the personnel of the SNHD Office of Epidemiology.  
The summary charts and tables are automatically updated in the customized Microsoft Excel 
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spreadsheet.  A small, yet revealing, summation of the past week is created, which contains 
an overview of any pertinent information found that week.  Once completed, it is then 
distributed weekly to a list of subscribers via e-mail or fax.   
 
Policies and procedures for patient privacy and confidentiality 
The data gathered are protected by Nevada Revised Statutes (NRS) 441A.22021. To 
further ensure patient privacy and confidentiality, all of the data are de-identified when given 
to the SNHD, Office of Epidemiology.   
 
Integration with other systems 
The PEWSS program does not currently integrate with any other system.  
 
Does the system comply with applicable records management program? 
 The data are kept in accordance with the Nevada Local Government Retention 
Schedule.  Therefore, the data are kept until the person reaches the age of 23 or six years 
from the date of collection, whichever is later.  The data, when destroyed, will be done in 
compliance with HIPAA security regulations and also in a manner in which it cannot be 
reconstructed, such as shredding.   
TASK	B3		
FUNDING	SOURCES	
 
Funding support for the 2010-2011 PEWSS program was provided by the Southern 
Nevada Health District and by an “Innovations in Quality Public Health Laboratory Practice” 
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grant provided by the Association of Public Health Laboratories (APHL).  The grant funding 
was provided through the following institutes: 
 National Center for HIV, Viral Hepatitis, STD and TB Prevention 
 Coordinating Center for Infectious Diseases 
 Office of Workforce and Career Development 
 National Center for Environmental Health 
 National Center for Zoonotic, Vector-borne, and Enteric Diseases 
 Coordinating Office of Global Health 
 Coordinating Office for Terrorism Preparedness and Emergency Response  
 National Center for Health Marketing 
 
COST	ANALYSIS	
 
A cost analysis of the PEWSS program was performed in three segments. Two were  
for the administration portion of the program, which consisted of the personnel of the SNHD, 
Office of Epidemiology, and the personnel of the SNPHL. The third analysis was conducted 
by the SNPHL, for the laboratory supplies of the program.   
ADMINISTRATIVE	COST	ANALYSIS	
 
To calculate the figures for the cost analysis, information regarding time spent on the 
PEWSS program was needed from the staff of the SNHD, Office of Epidemiology.  
Requested were the amount of time it took each worker to help in the startup of the PEWSS 
program and the estimated amount of time they spent per week working on the data and 
reporting for the PEWSS program.  The estimates were gathered and calculated into a yearly 
cost.  Also included in the final cost were the fringe benefits necessary for employment.  For 
the SNHD, Office of Epidemiology sentinel surveillance, the personnel cost for startup was 
estimated at $9,143, with a yearly upkeep average of $14,691 (Table 1). 
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		TABLE	1	COST	ANALYSIS	FOR	SNHD	AND	SNPHL	PERSONNEL	
 SNHD Office of 
Epidemiology
SNPHL 
Personnel
Total Cost 
     
Startup Personnel Cost 
including Fringe 
$9,143 $17,115 $26,258 
    
Yearly Maintenance Cost 
including Fringe 
$14,691 $50,220 $64,911 
Grand Total $23,834 $67,335 $91,169 
 
In the SNPHL, the startup process for the EPIS program was estimated at 280 hours. 
Using the same calculation, to include fringe benefits, the personnel cost for the SNPHL 
estimated at $17,115 (Table 1).  To determine an estimated yearly personnel cost, the average 
amount of time for one batch, which can consist of up to 7 samples, to run once a week, for 
one year, was estimated.  The average yearly maintenance for the personnel to analyze one 
batch every week for one year cost roughly $50,220 (Table 1).  This number will fluctuate 
depending on the quantity of specimens received throughout the year.  Not included in the 
cost of the analysis is the cost of the equipment along with maintenance contracts needed to 
maintain the instruments, office equipment, or proficiency and competency testing for staff. 
LABORATORY	SUPPLY	COST	ANALYSIS	
The final part of the cost analysis contained the laboratory equipment cost.  The cost 
of performing the influenza and non-influenza respiratory virus panel is dependent on the 
number of samples analyzed in each test batch.  The severity of respiratory illness in the 
community is the determining factor of how many batches of samples will be analyzed each 
week.  In high peak seasons, multiple batches will be analyzed each week, whereas in low 
peak seasons, batches might be analyzed every other week.  A batch can consist of one to 
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seven samples ran at one time. If only 1 sample is analyzed per test batch, the cost of 
extraction and test analysis at SNPHL for the entire panel is approximately $170.00 per 
sample.1   Because the PEWSS program is laboratory based surveillance and not diagnostic 
testing, sample extraction and analysis was primarily performed in batches of at least 7 
samples, to maximize the cost for each batch.  The batching of samples lowered the cost per 
sample and ensured that sufficient funding was available to complete the year long 
surveillance project.  If a batch of 7 samples are extracted and analyzed at the same time, the 
approximate cost for the panel is $55.00 per sample.1   The cost includes the price of 
extraction cartridges, master mix, probe/primer sets, controls, Applied Biosystems Inc. plates 
and caps.1  For one batch to run once a week it would cost $385.  Using the estimate, one 7 
sample batch ran every week for one year would cost $20,020.  This number is also subject 
to change depending on the quantity of specimens received in the laboratory.  
Overall, the total startup cost for both the SNPHL and the SNHD, was estimated at a 
yearly cost of $64,911 (Table 1).  The total cost for the personnel for both locations to startup 
the sentinel surveillance program was estimated at $91,169 (Table 1).  The cost of supplies to 
perform the test will add approximately another $20,020 to produce a final cost of 
$111,189/year.  These are approximate numbers and will fluctuate depending on the quantity 
of specimens received during the year.  The figures are also approximate costs of the time 
and money needed to start the program with resources readily available.  For the PEWSS 
program, funding for the personnel was not required because they were employed prior to 
setting up the program.  The funding necessary for the PEWSS program was obtained from 
the grants received to help aid in the cost of supplies.     
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TASK	C‐	FOCUS	THE	EVALUATION	DESIGN	
SPECIFIC	PURPOSE	OF	THE	EVALUATION	
 
The PEWSS program is a pilot public health program and therefore needs an 
evaluation to determine if it is an effective and useful system in relaying pertinent pediatric 
respiratory information to the community. 
IDENTIFYING	STAKEHOLDERS	WHO	WILL	RECEIVE	THE	FINDINGS	
 
The stakeholders, defined in Task A, along with others who may conduct similar 
programs, will be the recipients of the evaluation findings. 
WHAT	WILL	BE	DONE	WITH	THE	INFORMATION	GENERATED	FROM	THE	
EVALUATION?	
 
The information generated from this evaluation will have multiple uses.  One 
intended use of the findings will be for submission, by way of grant reviews, to the providers 
of the various grants that have allowed the PEWSS program to operate.  Another use will be 
to publish the findings of this evaluation in peer-reviewed journals, so that others may learn 
what has been found useful and what has not.  The program evaluation and its findings can 
also be used to help develop a base model program by others who wish to adopt the same 
design for use in their facility.   
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SPECIFYING	THE	QUESTIONS	THAT	WILL	BE	ANSWERED	BY	THE	EVALUATION	
 
The questions that will be answered by this evaluation are as follows: 
 Does the program flow efficiently and effectively? 
 Is the program cost effective? 
 Are the data relayed to the public in an effective manner? 
 
 
DETERMINING	STANDARDS	FOR	ASSESSING	THE	PERFORMANCE	OF	THE	SYSTEM	
 
Determining standards for assessing the PEWSS program consisted of a literature 
review to find similar surveillance based programs.  Searches for similar programs produced 
meager results.  Nothing was found to be similar in nature to the PEWSS program.  The end 
result showed there were no similar programs to compare standards or performance measures 
for the PEWSS program.  This showed the PEWSS program to be a stand-alone pilot 
program. 
TASK	D	–	GATHER	CREDIBLE	EVIDENCE	
SATISFACTORILY	ANSWER	QUESTIONS	
 
A system may be considered useful if it satisfactorily addresses at least one question 
out of six presented in the guidelines. Three of those six questions were adequately answered 
by this evaluation.  Does the system: 
 
1. Detect diseases of public importance in a timely way to permit accurate diagnosis or 
identification, prevention or treatment, and handling of contacts when appropriate? 
Yes.  The program does provide the information of current circulating pathogens that 
could help to increase the awareness of prevention measures to limit the spread of the 
pathogen. 
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2. Detect trends that signal changes in the occurrence of disease, injury or adverse or 
protective exposure, including detection of epidemics (or outbreaks)? 
Yes.  One of the objectives of the program is to develop trends for each pathogen.  If 
there are abnormal occurrences in a disease, it will show an increase on the PEWSS 
weekly bulletin notifying the Office of Epidemiology of increased seasonal cases or a 
potential outbreak.   
3. Lead to improved clinical, behavioral, social, policy, or environmental practices? 
Yes, the intention of this program is to inform health professionals about the diseases 
that are circulating to guide them as to which tests to use for clinical diagnosis.  This 
could potentially help in the decrease of performing unnecessary tests and cost to the 
patients.  The weekly bulletins can also be used by physicians to inform their patients 
of the viral etiology of the disease, which enforces the idea of not using antibiotics for 
treatment and reduces the improper use of antibiotics.  The information provided by 
the PEWSS bulletins will also remind the physicians about the importance of 
stressing the need for public health prevention to their patients during heightened 
times of pathogen occurrence. 
 
4. Provide estimates of the magnitude of morbidity and mortality related to the health 
related event under surveillance, including the identification of factors associated with the 
event? 
No 
5. Permit assessment of the effect of prevention and control programs? 
No 
6. Stimulate research intended to lead to prevention or control? 
No 
SYSTEM	ATTRIBUTES	
SIMPLICITY	
Rating: High 
This program has been kept simple on different aspects, from specimen collection and 
handling to the weekly bulletin.  The case definition has also been kept universal for all 
pathogens. Due to the ease of collection of specimens, the training is minimal. The SNPHL 
has taken on most of the specimen responsibility (i.e. testing and specimen transport), which 
eases the stress from the physicians and keeps consistency in the testing. There is no follow-
up with cases. However, there is follow-up if there are odd occurrences noticed within a 
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particular site.  There is no integration with other systems at this time. The weekly reports 
that are distributed are also simple and easy to understand, this was corroborated by the 
information gathered from surveys of the stakeholders. 
FLEXIBILITY	
Rating: High 
This program has the capability to add a new pathogen or an additional physician 
practice, if needed.  Blank spaces for each were built into the system for future expansion.  
Initially, 4 sites participated in the program.  A fifth site was added into the program, which 
took a minimal time of 1 week to incorporate into the PEWSS bulletins.  If a minor change to 
the case definition were to occur, the program would adapt effortlessly, because it is kept 
universal between all sites. However, if a complete change to the case definition were to 
occur, it would provide a challenge for future data comparison.  If personnel changed at the 
SNPHL, SNHD Office of Epidemiology, or any of the sites, it would not affect the 
functionality of the program, due to cross training at all locations.  If funds were to cease for 
this program, then the program itself would no longer exist.  The program could run if funds 
were reduced, but the detailed analysis of circulating pathogens would also be reduced. Lack 
of availability of funds is the least flexible area for this program.    
DATA	QUALITY	
Rating: High 
The data quality of the PEWSS program is complete and valid.  The specimen 
information is obtained when collected and given to the SNPHL.  The SNPHL has trained the 
pediatric office staff in proper specimen collection.  Once testing has occurred, the SNPHL 
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enter the data into a spreadsheet and checks the data for completeness.  This program does 
not need detailed patient information, other than date of birth and gender, for analysis in 
reporting, which helps to minimize clerical error.   
 
ACCEPTABILITY	
Rating: High 
The acceptability of this program, by the stakeholders, sentinel sites, staff of the 
SNPHL and the staff of the SNHD Office of Epidemiology, would be considered high.  The 
stakeholders expressed their acceptance of the program by the surveys conducted.  The 
pediatrician’s offices participate on a voluntary basis only, with the ability to opt out at any 
time.  The original four are still participating in the program and a fifth was added.  Each of 
the sites has also expressed their eagerness in participating in the program and in continued 
participation in the program.  Their continued enthusiasm and dedication earned them the 
honor of being named the 2011 Public Hero’s by the SNHD (Appendix I). In interviews with 
the SNPHL and the SNHD, they have also expressed their passion for the program and the 
information it provides to the medical community. 
SENSITIVITY	AND	PREDICTIVE	VALUE	POSITIVE	(PVP)	
 
Rating: Not Applicable 
The sensitivity of a system is based on the proportion of detected cases by a system.14  
Sensitivity can also be assessed on the ability to detect outbreaks.   Predictive Value Positive 
(PVP) is the proportion of reported cases that actually have the illness.14  These values are 
both calculated based on data that pools from an unbiased sample.  The calculation used for 
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both sensitivity and PVP, involves knowing the true and false positives and negatives of the 
system. This program uses sentinel surveillance with a specified biased data set.  The data 
being pooled are from a specific population, the sick pediatric population of Clark County, 
Nevada, visiting their pediatrician; also selected are the first ten that meet the criteria.  
Providing answers for either sensitivity or PVP would give a misunderstanding of the 
program. The PEWSS program does not look at sensitivity or PVP rates. Rather, it is more 
focused on trends, circulation and detection of different pathogens within the community.  It 
is possible for this program to detect outbreaks, which would be seen by a sudden spike of a 
pathogen, which would in turn serve as a warning for the SNHD, Office of Epidemiology, to 
investigate and administer public warnings and/or statements as needed. 
REPRESENTATIVENESS	
Rating: Medium 
This program uses 5 separate sentinel sites to gather data.  The sites were chosen by 
the volume of patients and by the mix of financial status of their patients.  By choosing the 
sites this way, the program can get a small, yet respectable, representation of children.  
However, using sentinel surveillance does not allow the results to be generalized to the entire 
population of pediatrics in the community2, because the sample is already biased.  This 
program is limited to only those families who have the ability to take their children to the 
doctor.  This program does not include pediatrics seen in clinic’s, emergency department 
visits, small clinics, etc. located around town.  However, knowing that most children visit 
their pediatricians office as their regular place of health care2, gives a comparable 
representation to the other locations visited. 
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TIMELINESS	
Rating: High 
Timeliness can consist of different factors. Specimens for analysis are collected three 
times a week.  Laboratory testing is performed once a week, unless there are too few 
specimens, in which case the specimens would be processed the following week.  If too few 
specimens are collected, the results for those specimens will be delayed, taking up to 14 days. 
This would occur during non-peak times of the year. Treatment of the patient is not delayed 
waiting for results; therefore, this is not a major concern for the physician. The data are 
analyzed and distributed once a week, regardless of the amount of specimens collected 
during the prior week.  According to both surveys, the sentinel site surveys and stakeholder 
surveys, the PEWSS program reports the information in a timely manner. 
STABILITY	
Rating: High 
The PEWSS program is an extremely stable and reliable system.  Machines are 
routinely maintained and serviced in the laboratory.  The computer equipment used by the 
SNPHL and the SNHD, Office of Epidemiology, are maintained by the Information 
Technology (IT) office, which includes the computer systems, printers, and servers.  Down 
time, due to computers or laboratory equipment, is at a very minimal level, due to the 
maintenance by the IT department.  Couriers are at the physician’s office routinely three 
times a week. If there is an inability by a courier to pickup samples at a location, there is a 
backup courier.  The reports are always compiled and sent by the SNHD, Office of 
Epidemiology.  If the primary person is unavailable, there are backups in place to ensure they 
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are distributed.  The program is operational 5 days a week, every year. The data are collected, 
tested and reported by the end of the week.  
TASK	E	‐	JUSTIFY	AND	STATE	CONCLUSIONS	AND	MAKE	
RECOMMENDATIONS	
 
The conclusion of this evaluation is, with the few known weaknesses, that the 
positive attributes are more than enough to show that the PEWSS pilot program is an 
efficient and effective program for accurately capturing and relaying the information to the 
stakeholders.  The purpose and the objectives of the PEWSS pilot program have been fully 
met by the program.  This evaluation has shown that the PEWSS program has the ability to 
keep the public informed in a timely manner about the currently circulating pathogens and 
that the program can and does create new relationships, as well as strengthen current 
relationships within the medical community.  All of the stakeholders involved have 
expressed their ongoing interest in the program.  The surveillance methods utilized by the 
SNPHL and the SNHD have shown to be cost effective, efficient, and preferred by the 
physicians, as demonstrated by their continued voluntary commitment to the program.  The 
strongest attributes of the PEWSS program are the acceptability by all of the stakeholders, 
simplicity of the program, flexibility, stability and timeliness.  Representativeness was rated 
at a medium level because sentinel surveillance does not allow results to be generalized to 
the population. However, knowing most children visit a pediatrician, it can be implied to be a 
good representation for the pediatric population. The cost of the program, if a laboratory and 
administrative office are already in place, is very feasible.  The highest cost is for the 
supplies used to create the kits for the physicians and the supplies to analyze the specimens.  
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Utilizing grants aid in the cost of the supplies.  Minimal time is used by both locations, 
sample batches are processed once a week and analysis of the specimen data is performed 
once a week.  The only limitations determined, were the attributes of sensitivity and 
predictive value positive, because they were not able to be calculated.  This is expected, 
using sentinel surveillance.  The PEWSS program does not look at the sensitivity or the 
positive predictive value.  The PEWSS program was generated with the intent to inform 
about circulating pathogens in the community and developing trends.  Therefore, sensitivity 
and the positive predictive value would not be a weak point of the program, rather not 
applicable to the PEWSS program.   
The operation of the PEWSS program has been streamlined by the personnel at the 
SNPHL and the SNHD, Office of Epidemiology.  There are no recommendations needed for 
the operation of the program.  The flow between the pediatrician’s office, the SNPHL and the 
SNHD, Office of Epidemiology, has been adjusted since the inception of the program.  The 
stakeholders did offer suggestions for the PEWSS bulletins.  Those suggestions were 
reviewed and implemented.  The bulletin was reorganized and restructured to include some 
of the suggestions (Appendix G).  For instance, an interpretation of the pathogen activity was 
added to Table 1. The age tables were eliminated, the weekly positive counts were modified 
so they were easier to read, and data gathered in previous years was included.  These changes 
were an accumulation of the stakeholder suggestions and the ideas from the staff at the 
SNHD, Office of Epidemiology. 
Task C asked for questions that would be answered by this evaluation.  The questions 
were, does the program flow efficiently and effectively, is it cost effective and does it relay 
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the data back to the community in an effective manner?  The answer is yes, it does all of the 
above.  The evidence gathered from the various tasks illustrates the efficiency and usefulness 
of this program.  The creators of this program have shown tremendous teamwork and 
collaboration to put together a one of a kind program that has gone beyond traditional 
surveillance not yet seen in this country.  Not only is the program very informative, but it has 
also been organized in an easily understandable manner to allow any person, not just those in 
the medical community, to understand what pathogens are circulating in the community.   
TASK	F	‐	ENSURE	USE	OF	EVALUATION	AND	FINDINGS	AND	SHARE	LESSONS	
LEARNED	
 
Determining who would do which tasks and when and where the specimens would 
come from were challenges.  Each department, and every person, had their own hurdles to 
overcome.  Some of these obstacles were which site to obtain samples from, train in the 
collection of samples, format weekly reports and who would write them every week.  These 
were all conquered, over time, to result in the currently smooth running system that works 
best for the SNPHL and the SNHD, Office of Epidemiology.   
The next question was what to do with the evaluation results.  For some of the grants 
used in the development of the program, a review is necessary to ensure effective and 
efficient use of the grant funds.  This evaluation will be part of those reviews.  Also, since 
this is a unique pilot program, the findings will also be submitted to a peer-reviewed journal 
for publication.  Lastly, other agencies will be able to review what has been done and to use 
this system as a base model for a similar program. 
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CHAPTER	4	‐	RESULTS	OF	THE	PEWSS	PROGRAM	DATA	ANALYSIS	
 
The first data set collected was during the time period of May 1st, 2009 through May 
31st, 2010.  Initially, these were collected for the EPIS program and tested for influenza.  
Once the program expanded to the PEWSS program, these nasal swab samples were retested, 
all at once, for the other pathogens.  There were 618 samples collected for analysis.  Eight of 
the samples were deleted from the data set.  One, was rejected due to being tested twice 
within a week time frame and the others were rejected due to being age 18 or over.  These 
deletions resulted in a sample set of 610 specimens (Appendix J). Table 2 lists the 
demographics for the first year EPIS program data set. Out of the 610 samples, 352 were 
positive (57.7%) for at least one pathogen.  Of those positive samples, 55.1% were male and 
44.9% were female.  The average age of patients with positive specimens, for the first data 
set, was 5.6 years, 5.9 years for females and 5.3 years for males.  Children aged 10 years and 
less accounted for 87.0% (n=306) of the positive specimens.  There were 10 co-infections 
found for the sample set (Table 3).  Eight of the ten were found to be males within one 
location.  The other two were female from two separate locations.  All ten were of age 10 
years and under. Other than influenza H1N1 involved in 6 of the 10 co-infections, there were 
no other patterns of pathogens found within the co-infections. 
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TABLE	2	DEMOGRAPHICS	OF	DATA	FROM	EPIS	PROGRAM,	05/01/09	TO	05/31/10	
  Female Male Total 
Total Specimens Collected (n,%) 259(42.5) 351(57.5) 610 
     
Total Positive Specimens (n,%) 158(44.9) 194(55.1) 352(57.7) 
     
Average Age of Positive Patient 
(years) 
5.9 5.3 5.6 
     
Virus Distribution    
 Adenovirus (n,%) 15(44.0) 19(56.0) 34(9.7) 
 HMPV (n,%) 4(40.0) 6(60.0) 10(2.8) 
 HPIV1 (n,%) 14(39.0) 22(61.0) 36(10.2) 
 HPIV2 (n,%) 1(50.0) 1(50.0) 2(0.57) 
 HPIV3 (n,%) 7(44.0) 9(56.0) 16(4.54) 
 Influenza A 111 130 241 
 Influenza AH1 0 0 0 
 Influenza H1N1 (n,%) 111(54.0) 130(46.0) 241(68.5) 
 Influenza H3 0 0 0 
 Influenza B (n,%) 0 1(100.0) 1(0.28) 
 RSV (n,%) 9(39.0) 14(61.0) 23(6.53) 
	
TABLE	3	CO‐INFECTIONS	OF	1ST	YEAR	DATA	SET	FOR	EPIS	PROGRAM,	05/01/09	TO	05/31/10	
Specimen 
Number 
Age 
(years) 
Gender Location CDC Week Virus 1 Virus 2 
1 10 Male 1 2009-23 Influenza H1N1 HMPV 
2 2 Male 1 2009-25 Influenza H1N1 HPIV3 
3 1 Male 1 2009-27 Adenovirus HPIV3 
4 2 Male 1 2009-28 Influenza H1N1 HPIV1 
5 <1 Male 1 2009-35 Influenza H1N1 RSV 
6 9 Female 3 2009-42 Influenza H1N1 HPIV1 
7 2 Male 1 2009-45 Influenza H1N1 Adenovirus 
8 3 Male 1 2009-49 Adenovirus RSV 
9 6 Female 2 2010-06 HMPV RSV 
10 1 Male 1 2010-20 Adenovirus HPIV3 
 
Each pathogen was analyzed for virus trends (Appendix J).  Out of the positive 
specimens tested, influenza H1N1 accounted for the highest amount at 68.5% (n=241), of 
which 54.0% were male (n=130) and 46.0% female (n=111), with an average age of 6.7 
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years, and 82.0% were 10 years and younger (n=198).  HPIV1 and adenovirus were next in 
prevalence with 10.2% and 9.7%, respectively.   Influenza A, excluding H1N1, had no 
positive samples for the year.  Influenza B had 1 positive sample, 0.28% of the positive 
specimens; a male aged 3 years.  RSV, 6.53% (n=23) of the positive specimens; 61.0% were 
male (n=14) and 39% were female (n=9) with an average age of 2.3 years.  Adenovirus, with 
an average age of 2.9 years, accounted for 34 positive specimens; 56.0% were male (n=19) 
and 44.0% were female (n=15). HPIV-1,with an average age of 3.9 years, had 36 total 
positive specimens; 61.0% were male (n=22) and 39.0% were female (n=14).  HPIV-2, 
0.57% (n=2) of the total positive specimens, with an average age of 7 years; one male and 
one female, both aged 7 years.  HPIV-3, 4.54% (n=16) of the total positive specimens, with 
an average age of 1.5 years, 56.0% were male (n=9) and 44.0% female (n=7).  HMPV, 2.8% 
(n=10) of the total positive specimens, with an average age of 5.4; 60.0% were male (n=6) 
and 40.0% female (n=4). 
The second data set, was collected June 1st, 2010 through May 31st, 2011. The 
demographic information is summarized in Table 4.  The data set (Appendix K) consisted of 
872 samples collected with 54.2% (n=473) that resulted in a positive test for at least one 
pathogen; females had 48.8% (n=231) positive specimens and males had 51.2% (n=242) 
positive specimens. Influenza A and RSV were the highest amount captured at 24.7% 
(n=117) and 21.1% (n=100), respectively. Influenza B and HPIV-3 were next with 16.7% 
(n=79) and 16.3% (n=77), respectively. The average age of positive specimens in the second 
data set was 4.4 years, with an average age of 4.5 years for females and 4.3 years for males.  
Children aged 10 years or less accounted for 89.9% (n=425) of the total positive specimens.  
There were 29 co-infections seen for this season, located throughout all 5 locations (Table 5).  
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RSV and influenza were the primary co-infections seen, and 10 of the 18 RSV co-infections 
also involved influenza.  RSV and influenza were involved in 62.1% (n=18) and 58.6% 
(n=17), respectively, of the co-infections.  
TABLE	4	DEMOGRAPHICS	OF	PEWSS	DATA	FROM	06/01/10	TO	05/31/11	
   Female Male Total 
Total Specimens Collected (n,%) 412(47.2) 460(52.8) 872 
       
Total Positive Specimens (n,%) 231(48.8) 242(51.2) 473(54.2) 
       
Average Age of Positive Patients 
(years) 4.53 4.33 4.43 
       
Virus Distribution      
  Adenovirus (n,%) 30(50.9) 29(49.2) 59(12.5) 
  HMPV (n,%) 16(55.2) 13(44.8) 29(6.1) 
  HPIV1 (n,%) 7(43.8) 9(56.3) 16(3.4) 
  HPIV2 (n,%) 15(57.7) 11(42.3) 26(5.5) 
  HPIV3 (n,%) 42(54.6) 35(45.5) 77(16.3) 
  Influenza A (n,%) 55(23.8) 62(13.1) 117(24.7) 
  Influenza AH1 0 0 0 
  Influenza H1N1 (n,%) 30(46.9) 34(53.1) 64(13.5) 
  Influenza H3 (n,%) 25(47.2) 28(52.8) 53(11.2) 
  Influenza B (n,%) 36(45.6) 43(54.4) 79(16.7) 
  RSV (n,%) 44(44.0) 56(56.0) 100(21.1) 
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TABLE	5	CO‐INFECTIONS	OF	2ND	YEAR	DATA	SET	FOR	PEWSS	PROGRAM,	06/01/10	TO	05/31/11	
Specimen 
Number 
Age 
(years) 
Gender Location CDC Week Virus 1 Virus 2 
1 2 Female 1 2010-24 HPIV3 RSV 
2 <1 Male 1 2010-27 HPIV3 RSV 
3 1 Male 2 2010-52 Flu B RSV 
4 2 Male 1 2011-01 H1N1 Adeno 
5 <1 Female 2 2011-02 H1N1 RSV 
6 <1 Female 3 2011-02 HPIV3 RSV 
7 1 Male 2 2011-03 AH3 RSV 
8 10 Male 1 2011-03 H1N1 RSV 
9 2 Male 1 2011-05 Flu B RSV 
10 8 Female 2 2011-06 Flu B RSV 
11 <1 Female 2 2011-06 H1N1 RSV 
12 1 Male 1 2011-06 HPIV1 RSV 
13 7 Female 2 2011-07 H1N1 RSV 
14 11 Male 4 2011-08 Adeno RSV 
15 1 Male 4 2011-08 Adeno RSV 
16 6 Male 4 2011-08 H1N1 RSV 
17 2 Male 4 2011-09 HPIV3 Flu B 
18 <1 Female 5 2011-09 Flu B RSV 
19 <1 Male 2 2011-11 HPIV3 AH3 
20 11 Female 4 2011-11 HPIV3 Flu B 
21 <1 Male 3 2011-11 HPIV3 H1N1 
22 3 Female 1 2011-12 Flu B HMPV 
23 3 Male 4 2011-13 Adeno HMPV 
24 1 Female 1 2011-14 HPIV3 Adeno 
25 1 Female 1 2011-14 Adeno RSV 
26 <1 Female 5 2011-15 Adeno HMPV 
27 8 Male 1 2011-15 HMPV RSV 
28 12 Male 3 2011-16 Adeno HMPV 
29 5 Female 4 2011-17 HPIV3 Flu B 
 
The PEWSS second year data set was analyzed for virus trends (Appendix K).  
Influenza A showed positive tests for H1N1 and H3; there were no positives for AH1 (Table 
4).  Influenza H1N1 had 64 positive samples; 53.1% (n=34) were male and 46.9% (n=30) 
were female.  Influenza AH3 resulted in 53 positive samples; 52.8% (n=28) were male and 
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47.2% (n=25) were female.  Influenza B had 79 positive samples; 54.4% (n=-43) were male 
and 45.6% (n=36) were female. RSV totaled 100 positive specimens; 56.0% (n=56) were 
male and 44.0% (n=44) were female.  Adenovirus, was 12.5% (n=59) of the positive 
specimens; 50.9% (n=30) were female and 49.2% (n=29) were male.  HMPV, 6.1% (n=29) 
of the positive specimens; 55.2% (n=16) were female and 44.8% (n=13) were male.   HPIV-1 
resulted in 16 positive samples, 3.4% of the total positive specimens; 56.3% (n=9) were male 
and 43.8% (n=7) were female.  HPIV-2 had 26 positive samples, 5.5% of the total positive 
specimens; 57.7% (n=15) were female and 42.30% (n=11) were male, and  HPIV-3 appeared 
in 77 positive samples; 54.6% (n=42) were female and 45.5% (n=35) were male (Table 4). 
The data collection process of the CDC consisted of individual laboratories, across 
the country, sending weekly data, that contained the information of all of respiratory tests 
conducted for the week.  The CDC recommends using the nasopharyngeal and oropharyngeal 
swabs for outpatient settings.  The specimen collection process of the PEWSS program and 
the recommended process of respiratory specimen collection by the CDC are similar 
methods.  The data provided by the CDC, division of NREVSS, were collected from May 1st, 
2009 through April 30, 2011.  Their data set did not include demographic data, other than the 
region in which the specimen was collected. The data set provided national and regional data 
for all the pathogens except for human metapnuemovirus.  Human metapnuemovirus is a 
recently discovered virus and is still under research at the CDC; therefore there are no data 
for comparison.  For the analysis, the data from the western region was used.  The western 
region contained data submitted from the states of California, Oregon, Washington, Montana, 
Idaho, Wyoming, Nevada, Utah, Colorado, Arizona, New Mexico and Alaska.7 
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Nellis Air Force Base (Nellis AFB) also contributed a data set from May 1st, 2009 
through April 30, 2011.  Not all of the respiratory pathogens collected by the PEWSS 
program were collected by Nellis Air Force Base.  Nellis AFB used the International 
Statistical Classification of Diseases and Related Health Problems (ICD) 9/10 codes when 
entering patient data into their database.  These codes do not provide detailed data on 
subtypes of the pathogens.  Therefore, not all pathogens can be compared to the PEWSS data 
sets when subtypes are involved.  Testing for other than RSV and influenza were not 
mandatory; any additional pathogens were not tested by physicians.  The data set provided 
included multiple entries for the same patient, due to multiple visits to a hospital/physician 
within the same day to a few days time.  All entries, for the same patient, within 2 weeks of 
the original date were deleted from the data set.  This was done to avoid duplicating the same 
admission or pathogen.  Two weeks were used as a cutoff date due to the average cycle 
length of time of the pathogens. The similar pathogens collected to the PEWSS program 
were RSV and influenza A. 
To plot all 3 data sets together (i.e., CDC, PEWSS, Nellis), the PEWSS data and the 
Nellis Air Force base data were date adjusted (Appendix L).  The PEWSS data set and the 
Nellis Air Force base data set were reformatted to coincide with the CDC weeks and the 
CDC data set.  Once the data sets were reformatted, all three were plotted on a Microsoft 
Excel graph together for comparison.   The CDC data were plotted on a second axis to 
accommodate the large number set.  All data sets were formatted similarly, with the 
exception of adenovirus, because both data sets were small in numbers. The PEWSS program 
data and the Nellis AFB data were plotted together, on separate charts for influenza and 
RSV, for local data comparison.  
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Overall, when examining the graphs (Appendix L), the data from the PEWSS 
program showed that the specimens collected accurately captured the data when compared to 
the CDC data and the data from Nellis Air Force Base.  Adenovirus (Appendix L-1) showed 
the sporadic nature of the pathogen during the two years shown for both the CDC and the 
PEWSS program.  Appendices L-2 and L-3, showed the comparison of RSV for all 3 
locations and the local comparison, respectively.  The first graph showed peak activity within 
similar time frames of all 3 data sets.  The second graph showed the local comparison of the 
data provided by the PEWSS program and data provided by Nellis AFB.  The peaks of 
activity coincide in the same time frame, which showed both locations were observing 
similar activity during the same time frame.  HPIV 1/2/3 (Appendix L-4 through L-6) have 3 
separate seasonality’s, with sporadic occurrences expected throughout the year.  However, 
for all three pathogens, when the CDC showed increased activity, so did the PEWSS program 
for all three HPIV pathogens.  Influenza A, subtypes not included, included all three 
locations (Appendix L-7).  The heightened peaks of activity occurred during the same time 
frame. The local comparison of the PEWSS program and Nellis AFB for influenza A 
(Appendix L-8) showed very similar activity.  However, the PEWSS program activity 
showed earlier activity than the Nellis AFB.  While the two seasons depicted for influenza 
H1N1 (Appendix L-9) are similar in nature, the PEWSS program does show a slightly earlier 
detection than the CDC data for both seasons.  Influenza B (Appendix L-10) showed similar 
findings of peak activity. 
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CHAPTER	5	‐	DISCUSSION	
  
Previous and ongoing research has provided the medical community with valuable 
information about respiratory illnesses, especially those which afflict pediatrics.  Respiratory 
illness is the second leading cause of death worldwide in children less than 5 years old.32 The 
pathogens are easily spread by person-to-person contact, airborne droplets, or inanimate 
objects.6 The influenza outbreak of 2009 caused over 1,000 deaths and 274,000 
hospitalizations as estimated by the CDC.5  Seasonality, demographics, signs and symptoms, 
prevention measures, and pathogenicity are just a few measures that have been greatly 
expanded over the years.  This knowledge has been of tremendous help to the medical 
community in identifying respiratory illnesses.  Coupled with surveillance, knowledge of 
pediatric respiratory illnesses that are circulating will be expanded, especially for the local 
public health community. 
The Pediatric Early Warning Sentinel Surveillance (PEWSS) program was begun in 
May 2009 by the Southern Nevada Health District (SNHD), Office of Epidemiology and the 
Southern Nevada Public Health Laboratory (SNPHL).  Using sentinel surveillance, they 
began collecting local data with the intent of giving the information back to the medical 
community to allow them to see what respiratory illnesses are currently circulating within the 
community.  This form of surveillance was the ideal method for the PEWSS program, since 
not all of the pathogens are mandated as reportable events.4 Sentinel surveillance also uses 
fewer resources than other systems and can give greater design flexibility.4 The PEWSS 
program provides the information on different respiratory pathogens, such as adenovirus, 
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respiratory syncytial virus (RSV), human parainfluenza 1, 2 &3, influenza A (with subtypes), 
influenza B, and human metapneumovirus. 
This study used the CDC “Updated guidelines for evaluating public health 
surveillance systems” to determine if this program was an effective and useful program and 
to streamline the goals and objectives of the program and also to improve the operation of the 
program.1  In the guidelines, it is mentioned that not all aspects of these guidelines will fit 
every program and that they should be tailored to the program being evaluated.  The rationale 
for the set of guidelines for this evaluation was to show the highlights of a program but also 
show portions that may need improvement.  This evaluation used all of the aspects described 
in the guidelines and also included additional items to further show different aspects not 
listed in the guidelines.    
Following the CDC guidelines, the strengths and weaknesses of the PEWSS program 
were emphasized.  In the guidelines, the goal was to find the opinions and thoughts of the 
stakeholders that receive the information, their attitude towards the program and the uses for 
the information provided by the bulletins. Surveys were conducted from both types of 
stakeholders, those that only read and use the information provided by the weekly bulletins, 
and those that provide the information for the weekly bulletins.  Both sides showed their high 
acceptance of the PEWSS program.  The sites that provide the samples are the base of the 
program.  The original four sites have continued their participation in the third year of the 
PEWSS program, along with the fifth site that was added this year.  The five sentinel sites 
were recognized as public health hero’s by the SNHD, Office of Epidemiology and the 
SNPHL, for their continued dedication to the PEWSS program and the community 
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(Appendix I).  The SNPHL and the SNHD, Office of Epidemiology, also made the specimen 
collection and testing process as easy as possible on the busy pediatrician offices.  SNPHL 
provided couriers and testing kits free of charge for the sites and the patients.  All the site had 
to do was collect the specimen and the SNPHL took care of the rest.  This provided 
convenience for the site and consistency for testing and handling of the specimens.  Task B 
asked for a cost analysis to show that the funds were being used effectively and efficiently. 
With people and equipment already in place, the cost analysis showed that minimal cost is 
needed to run the PEWSS program and grants were primarily used for the supplies needed.   
Task D, in the guidelines, looked at different components of the program and was 
divided into two parts.  The first part was the ability of the program to answer at least one of 
six questions outlined by the CDC guidelines. The PEWSS program could answer three of 
the six.  The second part of task D contained nine separate aspects targeted by the guidelines.  
This section highlighted some of the features of the PEWSS program; six of the nine 
components had a high rating.  The program rated high in simplicity, in the ease of the 
operation and structure, flexibility when needed, timeliness, high data quality, and high 
acceptance by multiple stakeholders and operators.  The program and the machinery needed 
to operate the program are very stable, with minimal downtime.  One component was rated 
medium, representativeness.  For routine surveillance, an unbiased sample is ideal.  That is 
not the case for this program; the sample population is preselected.    This is expected, using 
sentinel surveillance.  Sentinel surveillance, for the PEWSS program, selects those already 
sick to discover what illnesses are circulating in the community.  This is the basis for the 
program.  Therefore, representativeness is not a true weakness of the program.  The last two 
components, sensitivity and predictive value positive (PVP), were not rated for this program.  
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Both were not able to be calculated based on the program using sentinel surveillance and 
using a biased population. 
Another aspect not addressed by the CDC guidelines, was how accurate the PEWSS 
program was at capturing data within the community.  Extensive research has given us the 
knowledge of seasonality, trends, transmission, and etiologies of a variety of the respiratory 
illnesses, with the exception of the human metapneumovirus, which is a more recently 
discovered virus.   For this portion of the evaluation, data gathered by the CDC and Nellis 
Air Force Base were used for comparison.  Graphs were created and explored for the 
accuracy of the PEWSS program.  Using 2 separate scales, one for PEWSS and Nellis data 
set and the other for the CDC data set, time frames were compared.   
  When examining the trends between the PEWSS program, the CDC data and the 
data gathered from Nellis Air Force Base, activity was very similar throughout the two years 
of data collected.  RSV showed peak activity in all three data sets to occur at similar times 
during the two years (Appendix L-2).  Influenza A showed similar peak local activity 
(Appendix L-8), and both showed similar peak activities to the CDC national data (Appendix 
L-7).  Analogous results were seen for influenza H1N1 and influenza B, (Appendix L-9 and 
L-10 respectively).  The similar seasonal nature of all the respiratory pathogens shows the 
accuracy of the data gathered by the PEWSS program.  The local comparison between the 
PEWSS data and the Nellis AFB data showed similar seasonal activity between both 
locations, which further enforces the accuracy of the PEWSS program.   
One of the limitations of the program is the method used for surveillance.  Sentinel 
surveillance is not representative of the general public.4  The program represents those 
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children which visit the pediatrician office.  Excluded, are those who are slightly sick which 
do not visit the pediatrician’s office, those who cannot afford to visit a pediatrician’s office, 
or those who are extremely sick and visit an emergency room or clinic.  In 2008, 91.5% of 
children, under 18 years of age, had a visit with a doctor, compared to 82.5% of adults. 2,24  
Knowing that approximately three quarters of children visit a pediatrician’s office2 and 
95.2% have a usual place of health care2, the PEWSS program data from pediatrician’s 
offices can be better representative of activity than an emergency room or clinic.  Another 
limitation of study was the time frame allowed for responses for the public PEWSS bulletin 
survey.  Two weeks was given to allow for responses. Another limitation was that the 
specimens for the first year of the EPIS program were retroactively tested for all of the 
additional pathogens.  Originally, they were tested for H1N1 and then frozen. Later, they 
were thawed and then retested for the additional pathogens.  Possible sample destruction 
during the process may have occurred, leading to false negative results.  Improper specimen 
collection, also could lead to false negative results. 
Throughout the evaluation and data analysis, the Pediatric Early Warning 
Surveillance System has proven that it is an effective and useful program in that it accurately 
captures current trends in the community and also relays the information captured by the 
program in a timely and efficient manner. All of the people involved with the program have 
shown passion in continuing their involvement in the PEWSS program and its continued 
existence. The CDC evaluation guidelines have shown that the positive attributes far 
outweigh the foreseen weaknesses due to the type of surveillance used to conduct the 
program.  The additional data analysis reinforces the conclusion of the evaluation, the 
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PEWSS program is a brilliant program that accurately captures the data of the community 
and also does an exceptional job in relaying the information back to the community. 
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LIST	OF	ACRONYMS	AND	ABBREVIATIONS	
AFB 
Nellis Air Force Base 
APHL 
Association of Public Health Laboratories 
CDC 
Centers for Disease Control and Prevention 
EPIS 
Enhanced Pediatric Influenza Surveillance project 
FDA 
Food and Drug Administration 
HMPV 
Human Metapneumovirus 
HPIV 
Human Parainfluenza Virus 
ICD 
International Statistical Classification of Diseases and Related Health Problems 
ILI 
Influenza Like Illness 
IRB 
Institutional Review Board 
IT 
Information Technology 
MMWR 
Morbidity and Mortality Weekly Report 
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N/A 
Not Applicable 
NAC 
Nevada Administrative Code 
NREVSS 
National Respiratory and Enteric Virus Surveillance Program 
NRS 
Nevada Revised Statutes 
PEWSS 
Pediatric Early Warning Sentinel Surveillance System 
PVP 
Predictive Value Positive 
RSV 
Respiratory Syncytial Virus 
RT-PCR 
Reverse Transcriptase Polymerase Chain Reaction 
SNHD 
Southern Nevada Health District 
SNPHL 
Southern Nevada Public Health Laboratory 
VTM 
Viral Transport Medium 
WHO 
World Health Orginization
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Appendix A.
Checklist for Evaluating Public Health Surveillance Systems
Tasks for evaluating a surveillance system* Page(s) in this report
 Task A. Engage the stakeholders in the evaluation 4
 Task B. Describe the surveillance system to be evaluated 4–11
 1. Describe the public health importance of the health-related event under surveillance 4– 5
 a. Indices of frequency
 b. Indices of severity
 c. Disparities or inequities associated with the health-related event
 d. Costs associated with the health-related event
 e. Preventability
 f. Potential future clinical course in the absence of an intervention
 g. Public interest
 2. Describe the purpose and operation of the surveillance system 5–10
 a. Purpose and objectives of the system
 b. Planned uses of the data from the system
 c. Health-related event under surveillance, including case definition
 d. Legal authority for data collection
 e. The system resides where in organization(s)
 f. Level of integration with other systems, if appropriate
 g. Flow chart of system
 h. Components of system
 1) Population under surveillance
 2) Period of time of data collection
 3) Data collection
4)Reporting sources of data
 5) Data management
 6) Data analysis and dissemination
 7) Patient privacy, data confidentiality, and system security
 8) Records management program
 3. Describe the resources used to operate the surveillance system 10–11
 a. Funding source(s)
 b. Personnel requirements
 c. Other resources
 Task C. Focus the evaluation design 11–12
 1. Determine the specific purpose of the evaluation
 2. Identify stakeholders who will receive the findings and recommendations of the evaluation
 3. Consider what will be done with the information generated from the evaluation
 4. Specify the questions that will be answered by the evaluation
 5. Determine standards for assessing the performance of the system
 Task D. Gather credible evidence regarding the performance of the surveillance system 13–24
 1. Indicate the level of usefulness 13–14
 2. Describe each system attribute 14–24
 a. Simplicity
 b. Flexibility
 c. Data quality
 d. Acceptability
 e. Sensitivity
 f. Predictive value positive
 g. Representativeness
 h. Timeliness
 i. Stability
 Task E. Justify and state conclusions, and make recommendations 24
 Task F. Ensure use of evaluation findings and share lessons learned 25
* Adapted from Framework for Program Evaluation in Public Health [CDC. Framework for program evaluation in
public health. MMWR 1999;48(RR-11)] and the original guidelines [CDC. Guidelines for evaluating surveillance
systems. MMWR 1988;37(No. S-5)].
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Appendix B.
Cross-reference of Tasks and Relevant Standards
Tasks for evaluating a surveillance system* Relevant standards†
Task A. Engage the stakeholders Stakeholder identification. Persons involved in or
in the evaluation. affected by the evaluation should be identified so that
their needs can be addressed.
Evaluator credibility. The persons conducting the
evaluation should be trustworthy and competent in
performing the evaluation to ensure that findings from
the evaluation achieve maximum credibility and
acceptance.
Formal agreements. If applicable, all principal
parties involved in an evaluation should agree in
writing to their obligations (i.e., what is to be done,
how, by whom, and when) so that each party must
adhere to the conditions of the agreement or
renegotiate them.
Rights of human subjects. The evaluation should
be designed and conducted in a manner that respects
and protects the rights and welfare of human subjects.
Human interactions. Evaluators should interact
respectfully with other persons associated with an
evaluation so that participants are not threatened or
harmed.
Conflict of interest. Conflict of interest should be
handled openly and honestly so that the evaluation
processes and results are not compromised.
Metaevaluation. The evaluation should be forma-
tively and summatively evaluated against these and
other pertinent standards to guide its conduct
appropriately and, on completion, to enable close
examination of its strengths and weaknesses by
stakeholders.
Task B. Describe the surveillance system Complete and fair assessment. The evaluation
to be evaluated. should be complete and fair in its examination and
recording of strengths and weaknesses of the system
so that strengths can be enhanced and problem areas
addressed.
System documentation. The system being
evaluated should be documented clearly and
accurately.
Context analysis. The context in which the system
exists should be examined in enough detail to identify
probable influences on the system.
Metaevaluation. The evaluation should be
formatively and summatively evaluated against these
and other pertinent standards to guide its conduct
appropriately and, on completion, to enable close
examination of its strengths and weaknesses by
stakeholders.
Task C.  Focus the evaluation design. Evaluation impact. Evaluations should be planned,
conducted, and reported in ways that encourage
follow-through by stakeholders to increase the
likelihood of the evaluation being used.
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Appendix B. — Continued
Cross-reference of Tasks and Relevant Standards
Tasks for evaluating a surveillance system* Relevant standards†
Task C. (Continued ) Focus the evaluation design. Practical procedures. Evaluation procedures should
be practical while needed information is being
obtained to keep disruptions to a minimum.
Political viability. During the planning and
conducting of the evaluation, consideration should be
given to the varied positions of interest groups so that
their cooperation can be obtained and possible
attempts by any group to curtail evaluation operations
or to bias or misapply the results can be averted or
counteracted.
Cost-effectiveness. The evaluation should be
efficient and produce valuable information to justify
expended resources.
Service orientation. The evaluation should be
designed to assist organizations in addressing and
serving effectively the needs of the targeted
participants.
Complete and fair assessment. The evaluation
should be complete and fair in its examination and
recording of strengths and weaknesses of the system
so that strengths can be enhanced and problem areas
addressed.
Fiscal responsibility. The evaluator’s allocation and
expenditure of resources should reflect sound
accountability procedures by being prudent and
ethically responsible so that expenditures are
accountable and appropriate.
Described purpose and procedures. The purpose
and procedures of the evaluation should be monitored
and described in enough detail to identify and assess
them.  The purpose of evaluating a surveillance
system is to promote the best use of public health
resources by ensuring that only important problems
are under surveillance and that surveillance systems
operate efficiently.
Metaevaluation. The evaluation should be
formatively and summatively evaluated against these
and other pertinent standards to guide its conduct
appropriately and, on completion, to enable close
examination of its strengths and weaknesses by
stakeholders.
Task D. Gather credible evidence Information scope and selection. Information
regarding the performance of the collected should address pertinent questions
surveillance system. regarding the system and be responsive to the needs
and interests of clients and other specified
stakeholders.
Defensible information sources. Sources of
information used in the system evaluation should be
described in enough detail to assess the adequacy of
the information.
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Appendix B. — Continued
Cross-reference of Tasks and Relevant Standards
Tasks for evaluating a surveillance system* Relevant standards†
Task D. (Continued ) Gather credible evidence Valid information. Information-gathering
regarding the performance of the procedures should be developed and implemented to
surveillance system. ensure a valid interpretation for the intended use.
Reliable information. Information-gathering
procedures should be developed and implemented to
ensure sufficiently reliable information for the
intended use.
Systematic information. Information collected,
processed, and reported in an evaluation should be
systematically reviewed and any errors corrected.
Metaevaluation. The evaluation should be
formatively and summatively evaluated against these
and other pertinent standards to guide its conduct
appropriately and, on completion, to enable close
examination of its strengths and weaknesses by
stakeholders.
Task E. Justify and state conclusions, Values identification. The perspectives, procedures,
and make recommendations. and rationale used to interpret the findings should be
carefully described so that the bases for value
judgments are clear.
Analysis of information. Information should be
analyzed appropriately and systematically so that
evaluation questions are answered effectively.
Justified conclusions. Conclusions that are reached
should be explicitly justified for stakeholders’
assessment.
Metaevaluation. The evaluation should be
formatively and summatively evaluated against these
and other pertinent standards to guide its conduct
appropriately and, on completion, to enable close
examination of its strengths and weaknesses by
stakeholders.
Task F. Ensure use of evaluation findings Evaluator credibility. The persons conducting the
and share lessons learned. evaluation should be trustworthy and competent in
performing the evaluation to ensure that findings from
the evaluation achieve maximum credibility and
acceptance.
Report clarity. Evaluation reports should clearly
describe the system being evaluated, including its
context and the purposes, procedures, and findings of
the evaluation so that essential information is provided
and easily understood.
Report timeliness and dissemination. Substantial
interim findings and evaluation reports should be
disseminated to intended users so that they can be
used in a timely fashion.
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Appendix B. — Continued
Cross-reference of Tasks and Relevant Standards
Tasks for evaluating a surveillance system* Relevant standards†
Task F. Ensure use of the findings of the evaluation Evaluation impact. Evaluations should be planned,
and share lessons learned. conducted, and reported in ways that encourage
follow-through by stakeholders to increase the
likelihood of the evaluation being used.
Disclosure of findings. The principal parties of an
evaluation should ensure that the full evaluation
findings with pertinent limitations are made accessible
to the persons affected by the evaluation and any
others with expressed legal rights to receive the
results.
Impartial reporting. Reporting procedures should
guard against the distortion caused by personal
feelings and biases of any party involved in the
evaluation so that the evaluation reflects the findings
fairly.
Metaevaluation. The evaluation should be
formatively and summatively evaluated against these
and other pertinent standards to guide its conduct
appropriately and, on completion, to enable close
examination of its strengths and weaknesses by
stakeholders.
* Adapted from Framework for Program Evaluation in Public Health [CDC. Framework for program evaluation in
public health. MMWR 1999;48(RR–11)] and the original guidelines [CDC. Guidelines for evaluating surveillance
systems. MMWR 1988;37(No. S-5)].
† Adapted from Framework for Program Evaluation in Public Health [CDC. Framework for program evaluation in
public health. MMWR 1999;48(RR-11)].
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PEWSS Bulletin Users Survey 
1. How often do you receive the PEWSS bulletin:
 
Response 
Percent
Response 
Count
Every Week 73.7% 14
Frequently, but not every week 26.3% 5
Sporadically (from time to time)  0.0% 0
 answered question 19
 skipped question 0
2. How do you receive the PEWSS bulletin? (check all that apply)
 
Response 
Percent
Response 
Count
Directly from SNHD emails 89.5% 17
From the SNHD website 5.3% 1
Email that was forwarded  0.0% 0
Faxed from SNHD 5.3% 1
Faxed from someone else  0.0% 0
 answered question 19
 skipped question 0
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3. Do you forward the PEWSS bulletin to others?
 
Response 
Percent
Response 
Count
Yes 36.8% 7
No 63.2% 12
 answered question 19
 skipped question 0
4. To how many people do you forward it?
 
Response 
Percent
Response 
Count
1-4 42.9% 3
5-9  0.0% 0
10-19 14.3% 1
20+ 42.9% 3
 answered question 7
 skipped question 12
5. Have you ever read the PEWSS weekly bulletin?
 
Response 
Percent
Response 
Count
Yes 89.5% 17
No 10.5% 2
 answered question 19
 skipped question 0
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6. How often do you read the PEWSS bulletin?
 
Response 
Percent
Response 
Count
Every Week 64.7% 11
Frequently, but not every week 29.4% 5
Sporadically (from time to time) 5.9% 1
 answered question 17
 skipped question 2
7. Do you feel that the information in the PEWSS bulletins is:
 Very Somewhat Not at all
Rating 
Average
Response 
Count
Timely 88.2% (15) 11.8% (2) 0.0% (0) 1.12 17
Accurate 88.2% (15) 11.8% (2) 0.0% (0) 1.12 17
Relevant to you 82.4% (14) 17.6% (3) 0.0% (0) 1.18 17
Useful 88.2% (15) 11.8% (2) 0.0% (0) 1.12 17
Easy to read/understand 76.5% (13) 23.5% (4) 0.0% (0) 1.24 17
 answered question 17
 skipped question 2
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8. Do you use the PEWSS bulletin in the following ways:
 Frequently Occasionally Never
Rating 
Average
Response 
Count
To guide clinical diagnosis 29.4% (5) 35.3% (6) 35.3% (6) 2.06 17
To guide empirical treatment 23.5% (4) 23.5% (4) 52.9% (9) 2.29 17
To order laboratory testing 17.6% (3) 17.6% (3) 64.7% (11) 2.47 17
For general information 100.0% (17) 0.0% (0) 0.0% (0) 1.00 17
 answered question 17
 skipped question 2
9. What do you find most useful about the PEWSS bulletin?
 
Response 
Count
 
11
 answered question 11
 skipped question 8
10. What do you find least useful about the PEWSS bulletin?
 
Response 
Count
 
10
 answered question 10
 skipped question 9
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11. What (if any) improvements would you suggest be made to the bulletin?
 
Response 
Count
 
10
 answered question 10
 skipped question 9
12. What is your clinical practice setting (check all that apply)?
 
Response 
Percent
Response 
Count
Hospital 12.5% 2
Urgent Care 6.3% 1
Private Office 18.8% 3
Small Group Practice 12.5% 2
Large Group Practice 6.3% 1
Not Applicable 31.3% 5
Other 18.8% 3
Other 
 
2
 answered question 16
 skipped question 3
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13. What is your profession?
 
Response 
Percent
Response 
Count
Physician 37.5% 6
Physician Assistant  0.0% 0
Nurse (LPN/RN/APN etc.) 12.5% 2
Other medical staff  0.0% 0
Front office staff  0.0% 0
Laboratory Staff 12.5% 2
Administration Staff 6.3% 1
Public health Staff  0.0% 0
Educator 12.5% 2
Student  0.0% 0
Other (please specify) 
 
18.8% 3
 answered question 16
 skipped question 3
14. What is your specialty or primary area of practice?
 
Response 
Count
 
7
 answered question 7
 skipped question 12
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15. Are you part of the SNHD PEWSS distribution list?
 
Response 
Percent
Response 
Count
Yes 87.5% 14
No 12.5% 2
 answered question 16
 skipped question 3
16. If you would like to become a part of the SNHD PEWSS bulletin, please leave us your 
preferred choice of contact, fax or e-mail. For distribution purposes, please leave your 
name, e-mail address and/or fax number so we can add you to our weekly list.
 
Response 
Count
0
 answered question 0
 skipped question 19
17. If there are any comments you would like to make regarding the information contained 
in the PEWSS bulletin, please provide them here.
 
Response 
Count
 
5
 answered question 5
 skipped question 14
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Page 6, Q1.  What do you find most useful about the PEWSS bulletin?
1 Knowing the currently circulating respiratory viruses in the community Apr 28, 2011 7:50 AM
2 The virus report Apr 27, 2011 2:44 PM
3 Testing results (table 1) and weekly positivity rates (fig. 2) Apr 25, 2011 3:06 PM
4 The ages of the children that have tested for the specific illnesses. Apr 25, 2011 10:11 AM
5 Table 1- Testing Results etc. Apr 21, 2011 10:36 AM
6 current information Apr 21, 2011 7:00 AM
7 Frequency Apr 20, 2011 9:20 PM
8 Informative and lets me know what to look out for and pass the info to my
parents
Apr 20, 2011 8:22 PM
9 Helps me deteime what viruses are currently prevailing in the community Apr 20, 2011 4:11 PM
10 Specificly identified viral agents. Apr 20, 2011 3:49 PM
11 Provides information on viruses that are circulating in the community Apr 20, 2011 3:19 PM
Page 6, Q2.  What do you find least useful about the PEWSS bulletin?
1 the graphs Apr 28, 2011 7:50 AM
2 Small number of clinic sites Apr 27, 2011 2:44 PM
3 Age distribution data Apr 25, 2011 3:06 PM
4 Figure 2- Weekly Positivity Rates for Organisms Tested. Apr 25, 2011 10:11 AM
5 Figure 2 Weekly Graph Just do not need it in my program Apr 21, 2011 10:36 AM
6 never thought about that Apr 21, 2011 7:00 AM
7 Nothing Apr 20, 2011 9:20 PM
8 nothing Apr 20, 2011 8:22 PM
9 n/a Apr 20, 2011 3:49 PM
10 Does not contain additional information on treatment or testing.  Age breakdown
is not useful
Apr 20, 2011 3:19 PM
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Page 6, Q3.  What (if any) improvements would you suggest be made to the bulletin?
1 connect the data to national data. Apr 28, 2011 7:50 AM
2 Add more offices if able. Apr 27, 2011 2:44 PM
3 The graphs in figure 2 could be made more legible by expanding the y-axis and
making the line plot thinner, but this would require extra space and lenghten the
report
Apr 25, 2011 3:06 PM
4 Provide explinations of each chart to help us better understand the figures. Apr 25, 2011 10:11 AM
5 Would like more VPD results,  how about cases in the neighboring states? Apr 21, 2011 10:36 AM
6 nothing it fits my needs Apr 21, 2011 7:00 AM
7 Keep up the good work Apr 20, 2011 9:20 PM
8 none Apr 20, 2011 8:22 PM
9 None.  The bulletin assists in keeping abreast of what viral agents are out in the
community.
Apr 20, 2011 3:49 PM
10 Include technical information regarding recommended antiviral treatment; testing
capabilities; relevant websites
Apr 20, 2011 3:19 PM
Page 7, Q1.  What is your clinical practice setting (check all that apply)?
1 Pharmaceutical representative Apr 27, 2011 2:44 PM
2 Child Care Facility Apr 25, 2011 10:12 AM
Page 7, Q2.  What is your profession?
1 ICP Apr 21, 2011 7:00 AM
2 home day care Apr 20, 2011 8:22 PM
3 Day care provider Apr 20, 2011 7:32 PM
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Page 8, Q1.  What is your specialty or primary area of practice?
1 Pediatrics Apr 27, 2011 2:44 PM
2 med surg,rehab Apr 27, 2011 12:07 PM
3 Peds Apr 20, 2011 9:21 PM
4 Pediatrics Apr 20, 2011 4:12 PM
5 Preventive medicine. Apr 20, 2011 3:50 PM
6 Family Medicine Apr 20, 2011 3:10 PM
7 pediatrics Apr 20, 2011 2:42 PM
Page 11, Q1.  If there are any comments you would like to make regarding the information contained in the
PEWSS bulletin, please provide them here.
1 none Apr 27, 2011 12:07 PM
2 Excellent job, thanks! Apr 25, 2011 3:07 PM
3 no Apr 20, 2011 8:23 PM
4 I print the bulletin and post it on the door to keep my parents informed.I recently
discovered them.i used to delete them not knowing who it was from.They are
precious .Thank you.
Apr 20, 2011 4:04 PM
5 Provides timely information regarding the multiple types of viruses that are
circulating. The weekly reports are good, but an additional technical bulletin
provided on periodic basis would provide more information
Apr 20, 2011 3:22 PM
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PEWSS Laboratory Survey 
1. Which location are you at?
 
Response 
Percent
Response 
Count
Southwest Medical Pediatrics 26.3% 5
Lake Mead Pediatrics 15.8% 3
Foothills Pediatrics (S. Eastern) 15.8% 3
Foothills Pediatrics (Maryland 
Parkway) 10.5% 2
Fremont Childrens Clinic 31.6% 6
 answered question 19
 skipped question 0
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2. What is your profession?
 
Response 
Percent
Response 
Count
Physician 42.1% 8
Physician Assistant 5.3% 1
Nurse (LPN/RN/APN, etc.) 15.8% 3
Front Office 5.3% 1
Laboratory Staff  0.0% 0
Administration Staff 5.3% 1
Public Health Staff  0.0% 0
Other Medical Staff 15.8% 3
Educator  0.0% 0
Student  0.0% 0
Other 15.8% 3
Other (please specify) 
 
3
 answered question 19
 skipped question 0
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3. Please Answer
 
Strongly 
Agree
Agree Neutral Disagree
Strongly 
Disagree
Not 
Applicable
Response 
Count
SNHD and SNPHL have responded 
promptly to any request made to 
them by our facility staff
55.6% 
(10)
27.8% 
(5) 5.6% (1) 0.0% (0) 0.0% (0) 11.1% (2) 18
SNHD and SNPHL staff members 
are courteous and professional
68.4% 
(13)
26.3% 
(5) 5.3% (1) 0.0% (0) 0.0% (0) 0.0% (0) 19
SNPHL test requisition forms are 
easy to complete
68.4% 
(13)
26.3% 
(5) 5.3% (1) 0.0% (0) 0.0% (0) 0.0% (0) 19
Having SNPHLY couriers come on 
Monday, Wednesday and Friday 
for specimen pickup is easier then 
calling for pickup
78.9% 
(15)
21.1% 
(4) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 19
Patient laboratory reports provided 
by SNPHL are easy to understand 
and interpret
73.7% 
(14)
26.3% 
(5) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 19
PEWSS bulletins provided by 
SNHD Office of Epidemiology are 
easy to understand and interpret
63.2% 
(12)
36.8% 
(7) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 19
Our facility staff feels competent 
in collecting patient specimens
63.2% 
(12)
31.6% 
(6) 5.3% (1) 0.0% (0) 0.0% (0) 0.0% (0) 19
My overall satisfaction with SNHD 
and SNPHL service is high
68.4% 
(13)
31.6% 
(6) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 19
Our facility would recommend 
partnering with SNHD and SNPHL 
to colleagues
68.4% 
(13)
31.6% 
(6) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 19
It is useful for the office to be 
notified of interesting/unusual 
results by the SNHD Office of 
Epidemiology
68.4% 
(13)
26.3% 
(5) 5.3% (1) 0.0% (0) 0.0% (0) 0.0% (0) 19
 answered question 19
 skipped question 0
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4. Which staff members (doctor, nurse, medical assistant, etc.) in your facility collect nasal 
swabs for the PEWSS program?
 
Response 
Count
 
19
 answered question 19
 skipped question 0
5. Approximately what percent of patient visits to the facility are wellness checkups?
 
Response 
Count
 
18
 answered question 18
 skipped question 1
6. How do you receive the PEWSS bulletin?
 
Response 
Percent
Response 
Count
SNHD emails 52.9% 9
Email that was forwarded 17.6% 3
Faxed from someone else 17.6% 3
SNHD website 5.9% 1
Faxed from SNHD 52.9% 9
SNPHL courier 47.1% 8
Other 5.9% 1
 answered question 17
 skipped question 2
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7. To how many people do you forward the PEWSS bulletin
 
Response 
Percent
Response 
Count
0 52.9% 9
1-4 23.5% 4
5-9 17.6% 3
10-19  0.0% 0
20+ 5.9% 1
 answered question 17
 skipped question 2
8. How often do you read the PEWSS bulletin
 
Response 
Percent
Response 
Count
Every week 44.4% 8
Frequently but not every week 22.2% 4
Sporadically (from time to time) 27.8% 5
Never 5.6% 1
 answered question 18
 skipped question 1
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9. Do you use the PEWSS bulletins in the following ways
 
Response 
Percent
Response 
Count
To guide clinical diagnosis 44.4% 8
To guide emperical treatment 27.8% 5
To order laboratory testing 5.6% 1
For general information 77.8% 14
Not Used 11.1% 2
Other 5.6% 1
Other (please specify) 
 
1
 answered question 18
 skipped question 1
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10. Do you think the information in the PEWSS bulletins are:
 
Response 
Percent
Response 
Count
Timely 83.3% 15
Accurate 83.3% 15
Relevant to you 77.8% 14
Useful 88.9% 16
Easy to read/understand 88.9% 16
Not timely  0.0% 0
Not accurate  0.0% 0
Not relevant to you 5.6% 1
Not useful  0.0% 0
Not easy to read/understand  0.0% 0
 answered question 18
 skipped question 1
11. What do you find most and/or least useful about the PEWSS bulletin?
 
Response 
Count
 
8
 answered question 8
 skipped question 11
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12. What (if any) improvements would you suggest be made to the bulletin?
 
Response 
Count
 
8
 answered question 8
 skipped question 11
13. Are there any SNHD service areas that need improvement? Please identify the area and 
explain the specific problem(s)below, giving as much detail as possible and suggestions 
for improvement?
 
Response 
Count
 
8
 answered question 8
 skipped question 11
Page 1, Q2.  What is your profession?
1 medical assistant Jun 16, 2011 1:48 PM
2 medical assistant Jun 16, 2011 1:44 PM
3 Medical assistant Jun 16, 2011 1:13 PM
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Page 1, Q4.  Which staff members (doctor, nurse, medical assistant, etc.) in your facility collect nasal swabs for
the PEWSS program?
1 Doctor, nurse Jun 17, 2011 10:27 AM
2 doctor, medical assistants Jun 16, 2011 1:48 PM
3 medical assistant Jun 16, 2011 1:47 PM
4 Nurse Jun 16, 2011 1:46 PM
5 medical assistant, sometimes Dr. Duddy will do it Jun 16, 2011 1:44 PM
6 MA's Jun 16, 2011 1:29 PM
7 medical assistants Jun 16, 2011 1:13 PM
8 medical assistant Jun 16, 2011 1:11 PM
9 all nursing staff Jun 16, 2011 1:09 PM
10 myself, 2 other nurses, 2 doctors Jun 16, 2011 1:09 PM
11 the physicians and all 3 nurses (LPN's and RN's) Jun 16, 2011 1:07 PM
12 physicians, residents, nursing staff Jun 16, 2011 1:04 PM
13 Nurse Jun 16, 2011 1:02 PM
14 Dr. Taguha, Jose Lopez Jun 16, 2011 1:00 PM
15 Doctor, Medical Assitant Jun 16, 2011 12:59 PM
16 medical assistant, MD Jun 16, 2011 12:58 PM
17 medical assistant Jun 16, 2011 12:56 PM
18 Medical assistant Jun 16, 2011 12:54 PM
19 medical assistant Jun 16, 2011 12:52 PM
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Page 1, Q5.  Approximately what percent of patient visits to the facility are wellness checkups?
1 depends on time of year, 60% Jun 17, 2011 10:27 AM
2 60 Jun 16, 2011 1:48 PM
3 50 Jun 16, 2011 1:47 PM
4 40 Jun 16, 2011 1:46 PM
5 75 Jun 16, 2011 1:44 PM
6 40 Jun 16, 2011 1:29 PM
7 50% Jun 16, 2011 1:13 PM
8 50% Jun 16, 2011 1:11 PM
9 unknown Jun 16, 2011 1:09 PM
10 50% or more Jun 16, 2011 1:07 PM
11 50 Jun 16, 2011 1:04 PM
12 45 Jun 16, 2011 1:02 PM
13 60-70 Jun 16, 2011 1:00 PM
14 70 Jun 16, 2011 12:59 PM
15 70 Jun 16, 2011 12:58 PM
16 this time of year 75% Jun 16, 2011 12:56 PM
17 75%, during this time of year Jun 16, 2011 12:54 PM
18 50 Jun 16, 2011 12:52 PM
Page 2, Q9.  Do you use the PEWSS bulletins in the following ways
1 help in discussion with parents Jun 16, 2011 1:08 PM
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Page 2, Q11.  What do you find most and/or least useful about the PEWSS bulletin?
1 Influenza presence.  Also, I can show to patients to convince when antibiotic not
needed
Jun 17, 2011 10:29 AM
2 informative Jun 16, 2011 1:47 PM
3 too long Jun 16, 2011 1:29 PM
4 everything is very helpfull and understanding Jun 16, 2011 1:14 PM
5 the one sentence/paragraph summary... positive tests for xyz virus have been
detected
Jun 16, 2011 1:08 PM
6 the direct statement of what was found Jun 16, 2011 1:04 PM
7 reinforces ability to inform parents of viral etiology vs. bacteria Jun 16, 2011 1:03 PM
8 it is easy to read and understand Jun 16, 2011 12:56 PM
Page 2, Q12.  What (if any) improvements would you suggest be made to the bulletin?
1 n/a Jun 16, 2011 1:47 PM
2 none Jun 16, 2011 1:46 PM
3 list positive Jun 16, 2011 1:29 PM
4 none:) Jun 16, 2011 1:14 PM
5 n/a Jun 16, 2011 1:09 PM
6 better graphs Jun 16, 2011 1:04 PM
7 none Jun 16, 2011 12:56 PM
8 I wasn't aware of pediatric early warning surveillance Jun 16, 2011 12:53 PM
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Page 2, Q13.  Are there any SNHD service areas that need improvement? Please identify the area and explain the
specific problem(s)below, giving as much detail as possible and suggestions for improvement?
1 Advocate for our community with respect to non-vaccinators.  People "lie and tell
CCSD they are religiously opposed."  Use lortab in community. Advocate for
"medical home"
Jun 17, 2011 10:29 AM
2 n/a Jun 16, 2011 1:47 PM
3 seems fine Jun 16, 2011 1:46 PM
4 no Jun 16, 2011 1:45 PM
5 none:) Jun 16, 2011 1:14 PM
6 n/a Jun 16, 2011 1:09 PM
7 I am pleased with SNHD Jun 16, 2011 1:01 PM
8 none at this time Jun 16, 2011 12:56 PM
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Influenza A Positive* 0 0 0 0 0 130 0 0 0 0 117
%
All negative 5 45 5 38 7 64 9 64
% n % n % nPCR Testing Results n % n % n
2 33
5/21 5/28 6/4 6/11 6/18 Since 5/26/10
SNHD Pediatric Early Warning Sentinel Surveillance (PEWSS) Report: June 22, 2011
All Reporting Sites, Through the Week Ending June 18, 2011
General Update
The Southern Nevada Health District (SNHD) Pediatric Early Warning Sentinel Surveillance (PEWSS) has detected Human 
Metapneumovirus and Parainfluenza 1 for the week ending June 18, 2011.
The low number of patients who met testing criteria (fever >100°F accompanied by a cough and/or sore throat) and 
were able to provide specimens for testing this surveillance period (Fig. 1), coupled with the low variety of viruses 
detected (Table 1), suggest that both the types of respiratory viruses circulating in our community and their levels of 
circulation are low.
The PEWSS reports are disseminated weekly to the medical community by email, fax, and online at 
http://www.southernnevadahealthdistrict.org/stats-reports/influenza.php.  For questions about PEWSS, please contact 
the SNHD Office of Epidemiology at 702.759.1300.
Table 1 - Testing Results, Current Week and Previous Four Weeks
Week Ending Project to Date
* Includes Influenza of all subtypes
Southern Nevada Health District
Figure 1 - Weekly Number of Specimens Tested
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Figure 2 - Weekly Positivity Rates for Organisms Tested
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Figure 3. Age distributions of patients from whom specimens were tested and who tested positive
Tested Specimens Influenza A
Influenza A 2009 H1N1 Influenza A H1 (non‐2009 H1N1)
Influenza A H3 Influenza B
SNHD Pediatric Early Warning Sentinel Surveillance (PEWSS) Report: June 22, 2011
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Table 1 ‐ Testing Results, Current Week and Previous Four Weeks
PCR Testing Results n % n % n % n % n %
All negative 5 38% 7 64% 9 64% 2 33% 4 44%
Influenza A Positive 0 0% 0 0% 0 0% 0 0% 0 0%
Influenza B Positive 1 8% 0 0% 0 0% 0 0% 0 0%
Adenovirus Positive 1 8% 2 18% 0 0% 0 0% 1 11%
Human Metapneumovirus Positive 4 31% 0 0% 4 29% 3 50% 2 22%
P i fl 1 P iti 0 0% 1 9% 0 0% 1 17% 0 0%
5/28 6/4 6/11 6/18 6/25
All Reporting Sites, Through the Week Ending June 25, 2011
SNHD Pediatric Early Warning Sentinel Surveillance (PEWSS) Report: June 29, 2011
General Update
Sporadic
Low
S di
During the week ending June 25, 2011, the following viruses were identified with a low volume of testing: Adenovirus, 
Human Metapneumovirus and Parainfluenza 3.
Over the past five weeks:
Human Metapneumovirus and Parainfluenza 3 have been circulating in the community at low levels.
Influenza B, Adenovirus and Parainfluenza 1 have been sporadically identified in the community.
Influenza A and Parainfluenza 2 have not been identified in the communuity.
The PEWSS reports are disseminated weekly by email, fax, and online at http://www.southernnevadahealthdistrict.org/stats‐
reports/influenza.php.  For questions about PEWSS, please contact the SNHD Office of Epidemiology at 702.759.1300.
Not Detected
Sporadic
Week Ending
Interpretation
ara n uenza    os ve
Parainfluenza 2 Positive 0 0% 0 0% 0 0% 0 0% 0 0%
Parainfluenza 3 Positive 1 8% 1 9% 1 7% 0 0% 2 22%
RSV Positive 1 8% 0 0% 0 0% 0 0% 0 0%
Coinfections 0 0% 0 0% 0 0% 0 0% 0 0%
Specimens Tested 13 ‐ 11 ‐ 14 ‐ 6 ‐ 9 ‐
Table 2 ‐ Influenza A Typing, Current Week and Previous Four Weeks
Influenza A Typing (% of influenza A) n % n % n % n % n % n %
Influenza A 2009 H1N1 0 ‐ 0 ‐ 0 ‐ 0 ‐ 0 ‐ 0 ‐
Influenza A H1 0 ‐ 0 ‐ 0 ‐ 0 ‐ 0 ‐ 0 ‐
Influenza A H3 0 ‐ 0 ‐ 0 ‐ 0 ‐ 0 ‐ 0 ‐
Southern Nevada Health District
Low Volume
Not Detected
Low
Week Ending
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5‐Week Totals
Figure 1 ‐ Weekly Number of Specimens Tested
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SNHD Pediatric Early Warning Sentinel Surveillance (PEWSS) Report: June 29, 2011
Figure 2. Weekly Positive Counts for Organisims Tested
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Other News and Information
The format for the PEWSS weekly bulletins has been updated to display surveillance data from the previous year, and in 
response to replies from user surveys.
0
Pa
ra
flu
 2 
Po
sit
iv
es
0
10
Pa
ra
flu
 3
Po
sit
iv
es
0
10
20
RS
V
Po
sit
iv
es
7/3 7/31 8/28 9/25 10/23 11/20 12/18 1/15 2/12 3/12 4/9 5/7 6/4
87
P
ro
g
ra
m
:  
P
ed
ia
tr
ic
 E
ar
ly
 W
ar
ni
ng
 S
en
tin
el
 S
ur
ve
ill
an
ce
 (P
E
W
S
S
) L
og
ic
 M
od
el
 
S
itu
at
io
n
: 
S
ur
ve
ill
an
ce
 f
or
 la
b
or
at
o
ry
 c
on
fir
m
ed
 c
as
es
 o
f 
in
flu
en
za
 a
nd
 R
es
pi
ra
to
ry
 S
yn
cy
tia
l V
ir
u
s 
(R
S
V
) 
h
as
 b
ee
n 
co
n
du
ct
ed
 f
or
 s
ev
er
al
 y
ea
rs
 b
ut
 p
as
si
ve
 s
ys
te
m
s 
ar
e 
de
pe
nd
en
t 
on
 h
ea
lth
ca
re
 
p
ro
vi
d
er
s’
 i
nd
ex
 o
f 
su
sp
ic
io
n 
an
d 
th
ei
r 
d
ec
is
io
ns
 t
o
 t
es
t. 
 S
en
tin
el
 s
ite
 p
ed
ia
tr
ic
 s
ur
ve
ill
an
ce
 f
or
 t
h
es
e 
p
at
ho
ge
ns
 i
s 
su
p
er
io
r 
fo
r 
ea
rl
y 
de
te
ct
io
n
 o
f 
em
er
ge
n
ce
 o
f 
in
flu
en
za
 a
nd
 w
o
ul
d
 l
ik
el
y 
b
e 
su
p
er
io
r 
fo
r 
su
rv
ei
lla
n
ce
 a
nd
 fo
r 
de
te
ct
io
n 
o
f e
m
er
g
en
ce
 o
f o
th
er
 r
es
pi
ra
to
ry
 p
at
ho
g
en
s,
 p
o
te
n
tia
lly
 e
st
ab
lis
h
in
g 
se
as
on
al
it
y 
fo
r 
th
es
e 
p
at
ho
g
en
s.
 
R
es
ou
rc
es
 
 
A
ct
iv
iti
es
 
 
O
u
tp
u
ts
 
 
O
u
tc
om
es
 -
- I
m
p
ac
t  
 
 
S
h
o
rt
 
M
e
d
iu
m
 
L
o
n
g
 
 
F
un
di
ng
 to
 s
up
po
rt 
pr
og
ra
m
 
 
P
ur
ch
as
in
g 
se
rv
ic
es
 
 
 C
lin
ic
al
 L
ab
or
at
or
y 
S
ci
en
tis
t  
 
E
pi
de
m
io
lo
gi
st
 
 
C
ou
rie
r s
er
vi
ce
s  
 
Lo
ng
 te
rm
 s
am
pl
e 
st
or
ag
e  
 
6 
P
ed
ia
tr
ic
 S
en
tin
el
 S
ite
s  
 
La
bo
ra
to
ry
 S
up
pl
ie
s  
 
La
bo
ra
to
ry
 r
ea
ge
nt
s  
 
La
bo
ra
to
ry
 E
qu
ip
m
en
t  
 
W
rit
te
n 
P
ro
ce
du
re
s  
 
V
al
id
at
ed
 te
st
in
g 
m
et
ho
ds
 
 
T
ra
in
ed
 a
nd
 c
om
pe
te
nt
 
la
bo
ra
to
ry
 s
ta
ff  
 
B
ia
nn
ua
l p
ro
fic
ie
nc
y 
te
st
in
g  
m
at
er
ia
l 
E
va
lu
at
io
n 
to
ol
 fo
r 
se
nt
in
el
 s
ite
s  
 
E
va
lu
at
io
n 
to
ol
 fo
r O
O
E
 
an
d 
S
N
P
H
L  
 
 
S
ec
ur
e 
Fu
nd
in
g  
 
R
ec
ru
it 
S
en
tin
el
 S
ite
s  
 
T
ra
in
 s
en
tin
el
 s
ite
s 
on
 
pr
og
ra
m
 p
ro
ce
du
re
s,
 
sp
ec
im
en
 c
ol
le
ct
io
n 
an
d 
st
or
ag
e  
 
E
nc
ou
ra
gi
ng
 p
ro
gr
am
 
co
m
pl
ia
nc
e 
th
ro
ug
h 
di
re
ct
 c
on
ta
ct
 w
ith
 
se
n t
in
el
 s
ite
 s
ta
ff  
 
C
ol
le
ct
io
n 
of
 u
p 
to
 1
0 
re
sp
ira
to
ry
 s
am
pl
es
 a
t 
ea
ch
 s
en
tin
el
 s
ite
 p
er
 
w
ee
k  
 
T
ra
ns
po
rt 
of
 u
p 
to
 6
0 
re
sp
ira
to
ry
 s
am
pl
es
 
pe
r w
e e
k 
fr
om
 th
e 
6 
se
nt
in
el
 s
ite
s  
 
La
bo
ra
to
ry
 
ac
ce
ss
io
ni
ng
, 
ex
tr
ac
tio
n 
an
d 
an
al
ys
is
 o
f u
p 
to
 6
0 
sa
m
pl
es
 p
er
 w
ee
k  
 
P
ar
tic
ip
at
io
n 
in
 
bi
an
nu
al
 p
ro
fic
ie
nc
y 
te
st
in
g  
 
P
er
fo
rm
 in
iti
al
, 6
 
m
on
th
s 
an
d 
an
nu
al
 
te
ch
ni
ca
l s
ta
ff 
co
m
pe
te
nc
y  
 
P
ro
vi
de
 s
to
ra
ge
 o
f 
sa
m
pl
es
 fo
r p
os
si
bl
e 
fu
tu
re
 te
st
in
g  
 
P
er
fo
rm
 e
va
lu
at
io
n 
of
 
se
nt
in
el
 s
ite
s 
by
 O
O
E
 
an
d 
S
N
P
H
L  
 
P
er
fo
rm
 e
va
lu
at
io
n 
of
 
P
E
W
S
S
 p
ro
ce
ss
 a
nd
 
re
po
rti
ng
 b
y 
se
nt
in
el
 
si
te
s  
 
F
in
al
 in
di
vi
du
al
 te
st
 
re
po
rts
 a
re
 p
ro
vi
de
d 
to
 
se
nt
in
el
 s
ite
s  
 
F
in
al
 in
di
vi
du
al
 te
st
 
re
po
rts
 a
re
 p
ro
vi
de
d 
to
 
E
pi
de
m
io
lo
gy
 fo
r d
at
a 
an
al
ys
is
 
 
D
at
a 
is
 a
na
ly
ze
d 
fo
r 
tr
en
ds
 
 
D
at
a 
is
 re
po
rte
d 
at
 le
as
t 
m
on
th
ly
 a
nd
 u
p 
to
 
w
ee
kl
y 
if 
sp
ec
ifi
c  
di
se
a s
e 
tr
en
ds
 a
re
 
in
cr
ea
si
ng
  
 
Q
ua
rte
rly
 a
nd
 a
nn
ua
l 
re
po
rts
 d
ev
el
op
ed
 a
nd
 
di
st
rib
ut
ed
 
 
A
ss
es
sm
en
t o
f 
ev
al
ua
tio
ns
 p
er
fo
rm
ed
 
by
 s
en
tin
el
 s
ite
s,
 O
O
E
 
an
d 
S
N
P
H
L  
 
 
E
ar
ly
 d
et
ec
tio
n 
of
 
se
as
on
al
 
em
er
ge
nc
e 
of
 
re
sp
ira
to
ry
 
pa
th
og
en
s  
 
T
re
nd
in
g 
of
 
re
sp
ira
to
ry
 
pa
th
og
en
s  
 
A
va
ila
bi
lit
y 
of
 
sa
m
pl
es
 fo
r 
ad
di
tio
na
l 
ch
ar
ac
te
riz
at
io
n 
at
 
C
D
C
 
 
 
T
re
nd
in
g 
fo
r 
m
or
e 
re
sp
ira
to
ry
 
pa
th
og
en
s 
(b
es
id
es
 
in
flu
en
za
 a
nd
 
R
S
V
)  
 
P
ot
en
tia
l f
or
 
un
de
rs
ta
nd
in
g 
th
e 
se
as
on
al
ity
 o
f 
re
sp
ira
to
ry
 
pa
th
og
en
s 
be
si
de
s 
in
flu
en
za
 
an
d 
R
S
V
 
 
P
ot
en
tia
l f
or
 
as
si
st
in
g 
in
 
de
te
rm
in
in
g 
ca
us
e 
of
 
re
sp
ira
to
ry
 il
ln
es
s 
sp
ik
es
 s
ee
n 
in
 
sy
nd
ro
m
ic
 
su
rv
ei
lla
nc
e 
sy
st
em
s  
 
P
ot
en
tia
l t
o 
id
en
tif
y 
em
er
gi
ng
 
re
sp
ira
to
ry
 v
iru
s  
 
P
ot
en
tia
l t
o 
st
re
ng
th
en
 
co
m
m
un
ity
 
pa
rtn
er
sh
ip
s  
 
P
ot
en
tia
l f
or
 
de
ve
lo
pm
en
t o
f 
st
an
da
rd
iz
ed
 
pr
oc
es
s 
fo
r  
la
bo
ra
to
ry
 b
as
ed
 
su
rv
ei
lla
nc
e 
of
 
co
m
m
un
ity
 
in
fe
ct
io
us
 
di
se
as
e s
 
  
A
ss
um
pt
io
n
s  
 
E
xt
er
na
l F
ac
to
rs
 
P
ed
ia
tr
ic
 p
at
ie
nt
s 
ar
e 
un
iq
ue
ly
 s
us
ce
pt
ib
le
 to
 r
es
pi
ra
to
ry
 p
at
ho
ge
ns
 
P
ar
en
ts
 a
re
 m
or
e 
lik
el
y 
to
 s
ee
k 
he
al
th
ca
re
 fo
r i
ll 
ch
ild
re
n 
th
an
 fo
r t
he
m
se
lv
es
 if
 il
l w
ith
 re
sp
ira
to
ry
 s
ym
pt
om
s  
P
ed
ia
tr
ic
ia
ns
 d
o 
no
t r
ou
tin
el
y  
co
lle
ct
 la
bo
ra
to
ry
 s
pe
ci
m
en
s 
on
 s
ic
k 
ch
ild
re
n  
Id
en
tif
ic
at
io
n 
of
 th
e s
e 
vi
ru
se
s 
do
es
 n
ot
 u
su
al
ly
 p
ro
vi
de
 in
fo
rm
at
io
n 
cr
iti
ca
l t
o 
m
an
ag
em
en
t o
f t
he
 c
hi
ld
’s
 il
ln
es
s  
K
no
w
le
dg
e 
of
 v
iru
s 
ac
tiv
ity
 in
 th
e 
co
m
m
un
ity
 p
ro
vi
de
s 
va
lu
ab
le
 in
fo
rm
at
io
n 
fo
r p
ub
lic
 h
ea
lth
 p
re
ve
nt
io
n  
C
ha
rg
in
g 
pa
tie
nt
s 
fo
r t
he
 te
st
in
g 
is
 n
ot
 a
pp
ro
pr
ia
te
  
S
en
tin
el
 s
ite
 s
el
ec
tio
n 
an
d 
pa
rti
ci
pa
tio
n  
A
va
ila
bi
lit
y 
of
 c
ou
rie
r s
er
vi
ce
s 
to
 tr
an
sp
or
t c
ol
le
ct
ed
 s
am
pl
es
 
A
va
ila
bi
lit
y 
of
 v
al
id
at
ed
 la
bo
ra
to
ry
 te
st
s 
to
 d
et
ec
t v
iru
se
s  
A
va
ila
bi
lit
y 
of
 tr
ai
ne
d 
an
d 
co
m
pe
te
nt
 la
bo
ra
to
ry
 s
ta
ff  
A
va
ila
bi
lit
y 
of
 p
ro
fic
ie
nc
y 
m
at
er
ia
l f
or
 te
st
 m
et
ho
d  
A
va
ila
b i
lit
y 
of
 fu
nd
in
g  
 
 
R
ev
. 3
/1
0  
88
 
 
 
FOR IMMEDIATE RELEASE  
April 28, 2011 
Health District names Public Health Heroes 
 
LAS VEGAS – The Southern Nevada Health District announced its annual Public Health Heroes, 
recognition given to individuals or organizations whose efforts positively affect the health and well-
being of the community.  This year’s winners were honored at the April 28 Southern Nevada District 
Board of Health meeting.    
 
The 2011 Public Health Heroes are:  
 
Patrick Fogerty and Michael Schultz 
New York New York Hotel & Casino/ARK Restaurant Corporation 
Patrick Fogerty and Michael Schultz serve as the liaison between New York New York Hotel and Casino 
and ARK Restaurant Corporation and the health district. Fogerty and Schultz were named for their 
diligence regarding health district policies and regulations that impact their permitted establishments - 
whether they are leased outlets or hotel-owned food facilities. Both work closely with health district staff 
when they are obtaining new equipment or implementing new property practices to make sure they 
remain in compliance with health district permits, regulations and policies. Fogerty and Schultz 
maintain on-the-job training for all staff to ensure food handlers have an in-depth understanding of safe 
food handling practices. The two developed mock food inspection programs to support ARK Restaurant 
Corporation and property-owned food safety practices and public health policies, all of which ensure 
that the public and New York New York’s customers are protected.   
 
Pediatric Early Warning Sentinel Surveillance Sites:  
Foothills Pediatrics (2 clinics) – Henderson and Maryland Parkway clinics 
Fremont Children’s Clinic 
Lake Mead Pediatrics 
Southwest Medical Associates 
 
The Pediatric Early Warning Sentinel Surveillance System (PEWSS) was initiated in response to the 2009 
H1N1 influenza outbreak. It was developed to identify and track influenza in the community and in 
mid-2010, the system was expanded to cover the most common viral respiratory illnesses.   
 
PEWWS has been successful in providing an up-to-date picture of respiratory illness in Southern 
Nevada, and has provided valuable information to both the medical and public health communities. The 
success of this system is based on the voluntary participation of the five physician’s offices that make up 
the network, all of whom have maintained their commitment to the system.  
 
-more- 
  
89
2011 Public Health Heroes – add one  
 
The surveillance system information is reported to the medical community on a weekly basis. 
Information about the viral activity in the community can aid a physician in assessing the treatment 
options for patients. Through the hard work and dedication of the surveillance sites, the PEWSS system 
has provided (and continues to provide) valuable insight into disease patterns in our community.  
 
Candice Nichols, Executive Director 
Gay & Lesbian Center 
Candice Nichols has worked closely with the health district’s office of HIV/AIDS/STDs since 2004. 
Recently, Candice made the Gay & Lesbian Center available as an outreach site where anyone in the 
community can access HIV or STD testing. Candice and the Gay & Lesbian Center serve as a critical 
piece of the health district’s HIV/STD testing and counseling program. In addition to testing, at-risk 
individuals who visit the Center can also receive hepatitis A and B vaccinations. The goal of this 
outreach is to empower people with knowledge about their own health and disease status, and allows 
them to take control of their lives.  
 
Aurora Wong, Coordinator 
Hepatitis B Free Las Vegas 
Aurora Wong has created the Hepatitis B Free Las Vegas coalition to address the high rates of chronic 
hepatitis B infection among Asian Americans and Pacific Islanders in Southern Nevada, who have 
higher rates of infection than the general population.   
 
Since September, Wong has put together a coalition of 20 community partners, including the Southern 
Nevada Health District, and 100 stakeholders to develop an approach to educate and contain infection 
among the local Asian-American community. Her goal is to prevent new infections, to encourage testing 
and to help people who are infected with chronic hepatitis B become connected with resources and an 
appropriate system of care.   
 
This year’s awardees have shown tremendous initiative to ensure the conditions necessary to protect the 
health of Southern Nevada residents and visitors. All are well-deserving recipients of the Public Health 
Hero Awards. 
 
Public Health Heroes are nominated by health district staff members for their efforts in supporting one 
or more of the 10 Essential Public Health Services:  
1.  Monitor the health status to identify and solve community health problems.  
2.  Diagnose and investigate health problems and health hazards in the community 
3.  Inform, educate and empower people about health issues. 
4.  Mobilize community partnerships and action to identify and solve health problems.  
5.  Develop policies and plans that support individual and community health efforts. 
6.  Enforce laws and regulations that protect health and ensure safety. 
7.  Link people to needed personal health services and assure the provision of health care when 
otherwise unavailable. 
8.  Assure competent public and personal health care workforce. 
9.  Evaluate effectiveness, accessibility and quality of personal and population-based health services. 
10.  Research for new insights and innovative solution to health problems.  
 
Updated information about the Southern Nevada Health District can be found on Facebook 
www.facebook.com/SouthernNevadaHealthDistrict, on YouTube  www.youtube.com/SNHealthDistrict  
or Twitter: www.twitter.com/SNHDinfo. 
-30- 
90
 Ta
bl
e 
1 
Ag
e d
ist
rib
ut
io
n o
f a
ll 
sa
m
pl
es
 co
lle
ct
ed
 of
 1s
t y
ea
r 
da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 05
/0
1/
09
‐05
/3
1/
10
 
 
Ta
bl
e 
2 
Ag
e d
ist
rib
ut
io
n o
f a
ll 
po
si
tiv
e 
sa
m
pl
es
 co
lle
ct
ed
 of
 
1s
t y
ea
r d
at
a s
et
 fo
r P
EW
SS
 pr
og
ra
m
, 05
/0
1/
09
‐
05
/3
1/
10
 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
0 
12
 
40
 
52
 
0 
9 
17
 
26
 
1 
30
 
37
 
67
 
1 
21
 
18
 
39
 
2 
28
 
33
 
61
 
2 
18
 
18
 
36
 
3 
14
 
30
 
44
 
3 
7 
22
 
29
 
4 
18
 
29
 
47
 
4 
14
 
16
 
30
 
5 
19
 
28
 
47
 
5 
14
 
16
 
30
 
6 
24
 
23
 
47
 
6 
15
 
16
 
31
 
7 
16
 
30
 
46
 
7 
9 
21
 
30
 
8 
19
 
21
 
40
 
8 
11
 
15
 
26
 
9 
13
 
19
 
32
 
9 
4 
10
 
14
 
10
 
13
 
18
 
31
 
10
 
7 
8 
15
 
11
 
9 
6 
15
 
11
 
5 
5 
10
 
12
 
8 
8 
16
 
12
 
5 
3 
8 
13
 
13
 
7 
20
 
13
 
8 
3 
11
 
14
 
7 
9 
16
 
14
 
5 
2 
7 
15
 
5 
4 
9 
15
 
1 
1 
2 
16
 
7 
3 
10
 
16
 
4 
1 
5 
17
 
4 
6 
10
 
17
 
1 
2 
3 
To
ta
l 
25
9 
35
1 
61
0 
To
ta
l 
15
8 
19
4 
35
2 
Av
er
ag
e 
of
 A
ge
 
6.
4 
5.
4 
5.
9 
Av
er
ag
e 
of
 A
ge
 
5.
9 
5.
3 
5.
6 
   
 
91
 
 
Ta
bl
e 
3 
Ag
e D
ist
rib
ut
io
n o
f In
flu
en
za
 H
1N
1 S
am
pl
es
 
Co
lle
ct
ed
 of
 1s
t y
ea
r d
at
a s
et
 fo
r P
EW
SS
 pr
og
ra
m
, 
05
/0
1/
09
‐05
/3
1/
10
 
 
Ta
bl
e 
4 
Ag
e D
ist
rib
ut
io
n o
f In
flu
en
za
 B
 Sa
m
pl
es
 Co
lle
ct
ed
 of
 
1s
t y
ea
r d
at
a s
et
 fo
r P
EW
SS
 pr
og
ra
m
, 05
/0
1/
09
‐
05
/3
1/
10
 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
0 
4 
6 
10
 
0 
0 
0 
0 
1 
9 
5 
14
 
1 
0 
0 
0 
2 
9 
10
 
19
 
2 
0 
0 
0 
3 
5 
14
 
19
 
3 
0 
1 
1 
4 
9 
7 
16
 
4 
0 
0 
0 
5 
11
 
12
 
23
 
5 
0 
0 
0 
6 
11
 
12
 
23
 
6 
0 
0 
0 
7 
7 
16
 
23
 
7 
0 
0 
0 
8 
8 
15
 
23
 
8 
0 
0 
0 
9 
4 
10
 
14
 
9 
0 
0 
0 
10
 
7 
7 
14
 
10
 
0 
0 
0 
11
 
4 
5 
9 
11
 
0 
0 
0 
12
 
5 
3 
8 
12
 
0 
0 
0 
13
 
7 
3 
10
 
13
 
0 
0 
0 
14
 
5 
1 
6 
14
 
0 
0 
0 
15
 
1 
1 
2 
15
 
0 
0 
0 
16
 
4 
1 
5 
16
 
0 
0 
0 
17
 
1 
2 
3 
17
 
0 
0 
0 
Gr
an
d 
To
ta
l 
11
1 
13
0 
24
1 
Gr
an
d 
To
ta
l 
0 
1 
1 
Av
er
ag
e 
of
 A
ge
 
7.
0 
6.
4 
6.
7 
Av
er
ag
e 
of
 A
ge
 
0.
0 
3.
0 
3.
0 
 
92
 Ta
bl
e 
5 
Ag
e D
ist
rib
ut
io
n o
f R
SV
 Sa
m
pl
es
 Co
lle
ct
ed
 of
 1s
t 
ye
ar
 da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 05
/0
1/
09
‐
05
/3
1/
10
 
Ta
bl
e 
6 
Ag
e D
ist
rib
ut
io
n o
f A
de
no
vi
ru
s S
am
pl
es
 Co
lle
ct
ed
 of
 
1s
t y
ea
r d
at
a s
et
 fo
r P
EW
SS
 pr
og
ra
m
, 05
/0
1/
09
‐
05
/3
1/
10
 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
0 
0 
5 
5 
0 
2 
4 
6 
1 
2 
2 
4 
1 
5 
3 
8 
2 
5 
2 
7 
2 
1 
3 
4 
3 
0 
2 
2 
3 
1 
4 
5 
4 
0 
1 
1 
4 
1 
2 
3 
5 
0 
0 
0 
5 
1 
2 
3 
6 
2 
2 
4 
6 
1 
0 
1 
7 
0 
0 
0 
7 
0 
1 
1 
8 
0 
0 
0 
8 
2 
0 
2 
9 
0 
0 
0 
9 
0 
0 
0 
10
 
0 
0 
0 
10
 
0 
0 
0 
11
 
0 
0 
0 
11
 
0 
0 
0 
12
 
0 
0 
0 
12
 
0 
0 
0 
13
 
0 
0 
0 
13
 
1 
0 
1 
14
 
0 
0 
0 
14
 
0 
0 
0 
15
 
0 
0 
0 
15
 
0 
0 
0 
16
 
0 
0 
0 
16
 
0 
0 
0 
17
 
0 
0 
0 
17
 
0 
0 
0 
Gr
an
d 
To
ta
l 
9 
14
 
23
 
Gr
an
d 
To
ta
l 
15
 
19
 
34
 
Av
er
ag
e 
of
 A
ge
 
2.
7 
2.
0 
2.
3 
Av
er
ag
e 
of
 A
ge
 
3.
6 
2.
4 
2.
9 
   
93
Ta
bl
e 
7 
Ag
e D
ist
rib
ut
io
n o
f H
PI
V‐
1 S
am
pl
es
 Co
lle
ct
ed
 of
 1s
t 
ye
ar
 da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 05
/0
1/
09
‐
05
/3
1/
10
 
 
Ta
bl
e 
8 
Ag
e D
ist
rib
ut
io
n o
f H
PI
V‐
2 S
am
pl
es
 Co
lle
ct
ed
 of
 1s
t 
ye
ar
 da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 05
/0
1/
09
‐
05
/3
1/
10
 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
0 
1 
2 
3 
0 
0 
0 
0 
1 
3 
4 
7 
1 
0 
0 
0 
2 
1 
2 
3 
2 
0 
0 
0 
3 
1 
2 
3 
3 
0 
0 
0 
4 
3 
5 
8 
4 
0 
0 
0 
5 
1 
2 
3 
5 
0 
0 
0 
6 
0 
1 
1 
6 
0 
0 
0 
7 
1 
3 
4 
7 
1 
1 
2 
8 
1 
0 
1 
8 
0 
0 
0 
9 
1 
0 
1 
9 
0 
0 
0 
10
 
0 
1 
1 
10
 
0 
0 
0 
11
 
1 
0 
1 
11
 
0 
0 
0 
12
 
0 
0 
0 
12
 
0 
0 
0 
13
 
0 
0 
0 
13
 
0 
0 
0 
14
 
0 
0 
0 
14
 
0 
0 
0 
15
 
0 
0 
0 
15
 
0 
0 
0 
16
 
0 
0 
0 
16
 
0 
0 
0 
17
 
0 
0 
0 
17
 
0 
0 
0 
Gr
an
d 
To
ta
l 
14
 
22
 
36
 
Gr
an
d 
To
ta
l 
1 
1 
2 
Av
er
ag
e 
of
 A
ge
 
4.
3 
3.
7 
3.
9 
Av
er
ag
e 
of
 A
ge
 
7.
0 
7.
0 
7.
0 
   
94
Ta
bl
e 
9 
Ag
e D
ist
rib
ut
io
n o
f H
PI
V‐
3 S
am
pl
es
 Co
lle
ct
ed
 of
 1s
t 
ye
ar
 da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 05
/0
1/
09
‐
05
/3
1/
10
 
Ta
bl
e 
10
 
Ag
e D
ist
rib
ut
io
n o
f H
M
PV
 Sa
m
pl
es
 Co
lle
ct
ed
 of
 1s
t 
ye
ar
 da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 05
/0
1/
09
‐
05
/3
1/
10
 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
0 
2 
1 
3 
0 
0 
0 
0 
1 
2 
5 
7 
1 
0 
1 
1 
2 
1 
3 
4 
2 
1 
1 
2 
3 
0 
0 
0 
3 
1 
0 
1 
4 
1 
0 
1 
4 
0 
1 
1 
5 
1 
0 
1 
5 
0 
0 
0 
6 
0 
0 
0 
6 
2 
1 
3 
7 
0 
0 
0 
7 
0 
0 
0 
8 
0 
0 
0 
8 
0 
0 
0 
9 
0 
0 
0 
9 
0 
0 
0 
10
 
0 
0 
0 
10
 
0 
1 
1 
11
 
0 
0 
0 
11
 
0 
0 
0 
12
 
0 
0 
0 
12
 
0 
0 
0 
13
 
0 
0 
0 
13
 
0 
0 
0 
14
 
0 
0 
0 
14
 
0 
1 
1 
15
 
0 
0 
0 
15
 
0 
0 
0 
16
 
0 
0 
0 
16
 
0 
0 
0 
17
 
0 
0 
0 
17
 
0 
0 
0 
Gr
an
d 
To
ta
l 
7 
9 
16
 
Gr
an
d 
To
ta
l 
4 
6 
10
 
Av
er
ag
e 
of
 A
ge
 
1.
9 
1.
2 
1.
5 
Av
er
ag
e 
of
 A
ge
 
4.
3 
6.
2 
5.
4 
 
95
Ta
bl
e 
1 
Ag
e d
ist
rib
ut
io
n o
f a
ll 
sa
m
pl
es
 co
lle
ct
ed
 of
 2n
d y
ea
r d
at
a s
et
 
fo
r P
EW
SS
 pr
og
ra
m
, 06
/0
1/
10
‐05
/3
1/
11
 
 
Ta
bl
e 
2 
Ag
e d
ist
rib
ut
io
n o
f a
ll 
po
si
tiv
e 
sa
m
pl
es
 co
lle
ct
ed
 of
 2n
d y
ea
r 
da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 06
/0
1/
10
‐05
/3
1/
11
 
  
  
  
  
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
0 
43
 
51
 
94
 
0 
24
 
25
 
49
 
1 
63
 
80
 
14
3 
1 
36
 
46
 
82
 
2 
47
 
47
 
94
 
2 
31
 
27
 
58
 
3 
45
 
58
 
10
3 
3 
29
 
37
 
66
 
4 
33
 
34
 
67
 
4 
22
 
15
 
37
 
5 
28
 
42
 
70
 
5 
14
 
26
 
40
 
6 
21
 
24
 
45
 
6 
11
 
12
 
23
 
7 
23
 
17
 
40
 
7 
14
 
6 
20
 
8 
24
 
19
 
43
 
8 
14
 
7 
21
 
9 
17
 
17
 
34
 
9 
11
 
8 
19
 
10
 
8 
16
 
24
 
10
 
3 
7 
10
 
11
 
9 
13
 
22
 
11
 
5 
8 
13
 
12
 
9 
13
 
22
 
12
 
4 
6 
10
 
13
 
11
 
8 
19
 
13
 
3 
3 
6 
14
 
11
 
6 
17
 
14
 
2 
3 
5 
15
 
10
 
8 
18
 
15
 
3 
4 
7 
16
 
6 
3 
9 
16
 
2 
1 
3 
17
 
4 
4 
5 
17
 
2 
0 
2 
Gr
an
d 
To
ta
l 
41
1 
45
8 
87
2 
To
ta
l 
23
0 
24
1 
47
1 
  
  
  
  
Av
er
ag
e 
Ag
e 
6.
4 
5.
4 
5.
9 
Av
er
ag
e 
Ag
e 
4.
5 
4.
3 
4.
4 
 
96
Ta
bl
e 
3 
Ag
e d
ist
rib
ut
io
n o
f a
ll in
flu
en
za
 H
1N
1 s
am
pl
es
 co
lle
ct
ed
 of
 
2n
d y
ea
r d
at
a s
et
 fo
r P
EW
SS
 pr
og
ra
m
, 06
/0
1/
10
‐05
/3
1/
11
 
  
Ta
bl
e 
4 
Ag
e d
ist
rib
ut
io
n o
f a
ll in
flu
en
za
 A
H1
 sa
m
pl
es
 co
lle
ct
ed
 of
 
2n
d y
ea
r d
at
a s
et
 fo
r P
EW
SS
 pr
og
ra
m
, 06
/0
1/
10
‐05
/3
1/
11
 
  
  
  
  
  
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
  
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
0 
6 
3 
9 
  
0 
0 
0 
0 
1 
2 
3 
5 
  
1 
0 
0 
0 
2 
4 
5 
9 
  
2 
0 
0 
0 
3 
0 
3 
3 
  
3 
0 
0 
0 
4 
3 
1 
4 
  
4 
0 
0 
0 
5 
4 
6 
10
 
  
5 
0 
0 
0 
6 
0 
2 
2 
  
6 
0 
0 
0 
7 
1 
2 
3 
  
7 
0 
0 
0 
8 
0 
0 
0 
  
8 
0 
0 
0 
9 
2 
1 
3 
  
9 
0 
0 
0 
10
 
0 
2 
2 
  
10
 
0 
0 
0 
11
 
2 
3 
5 
  
11
 
0 
0 
0 
12
 
2 
2 
4 
  
12
 
0 
0 
0 
13
 
1 
1 
2 
  
13
 
0 
0 
0 
14
 
0 
0 
0 
  
14
 
0 
0 
0 
15
 
1 
0 
1 
  
15
 
0 
0 
0 
16
 
1 
0 
1 
  
16
 
0 
0 
0 
17
 
1 
0 
1 
  
17
 
0 
0 
0 
To
ta
l 
30
 
34
 
64
 
  
To
ta
l 
0 
0 
0 
  
  
  
  
  
Av
er
ag
e 
Ag
e 
5.
8 
5.
3 
5.
5 
  
Av
er
ag
e 
Ag
e 
0.
0 
0.
0 
0.
0 
 
97
Ta
bl
e 
5 
Ag
e d
ist
rib
ut
io
n o
f a
ll in
flu
en
za
 A
H3
 sa
m
pl
es
 co
lle
ct
ed
 of
 
2n
d y
ea
r d
at
a s
et
 fo
r P
EW
SS
 pr
og
ra
m
, 06
/0
1/
10
‐05
/3
1/
11
 
Ta
bl
e 
6 
Ag
e d
ist
rib
ut
io
n o
f a
ll in
flu
en
za
 B
 sa
m
pl
es
 co
lle
ct
ed
 of
 2n
d 
ye
ar
 da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 06
/0
1/
10
‐05
/3
1/
11
 
  
  
  
  
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
0 
0 
3 
3 
0 
1 
1 
2 
1 
2 
4 
6 
1 
2 
1 
3 
2 
3 
1 
4 
2 
3 
3 
6 
3 
2 
4 
6 
3 
6 
3 
9 
4 
4 
3 
7 
4 
2 
2 
4 
5 
2 
7 
9 
5 
2 
6 
8 
6 
1 
1 
2 
6 
2 
6 
8 
7 
3 
2 
5 
7 
3 
2 
5 
8 
2 
1 
3 
8 
7 
3 
10
 
9 
2 
0 
2 
9 
3 
7 
10
 
10
 
0 
0 
0 
10
 
0 
2 
2 
11
 
1 
1 
2 
11
 
2 
1 
3 
12
 
0 
0 
0 
12
 
0 
2 
2 
13
 
0 
0 
0 
13
 
2 
1 
3 
14
 
1 
1 
2 
14
 
0 
1 
1 
15
 
2 
0 
2 
15
 
0 
1 
1 
16
 
0 
0 
0 
16
 
0 
0 
0 
17
 
0 
0 
0 
17
 
0 
0 
0 
To
ta
l 
25
 
28
 
53
 
To
ta
l 
35
 
42
 
77
 
  
  
  
  
Av
er
ag
e 
Ag
e 
6.
2 
4.
2 
5.
2 
Av
er
ag
e 
Ag
e 
6.
3 
7.
1 
6.
7 
 
98
Ta
bl
e 
7 
Ag
e d
ist
rib
ut
io
n o
f a
ll R
SV
 sa
m
pl
es
 co
lle
ct
ed
 of
 2n
d y
ea
r 
da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 06
/0
1/
10
‐05
/3
1/
11
 
 
Ta
bl
e 
8 
Ag
e d
ist
rib
ut
io
n o
f a
ll a
de
no
vi
ru
s s
am
pl
es
 co
lle
ct
ed
 of
 2n
d 
ye
ar
 da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 06
/0
1/
10
‐05
/3
1/
11
 
  
  
  
  
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
0 
8 
7 
15
 
0 
3 
4 
7 
1 
6 
17
 
23
 
1 
10
 
10
 
20
 
2 
9 
6 
15
 
2 
0 
3 
3 
3 
5 
10
 
15
 
3 
7 
4 
11
 
4 
4 
4 
8 
4 
3 
1 
4 
5 
2 
3 
5 
5 
2 
0 
2 
6 
2 
1 
3 
6 
1 
1 
2 
7 
4 
0 
4 
7 
2 
0 
2 
8 
3 
2 
5 
8 
1 
1 
2 
9 
1 
0 
1 
9 
0 
0 
0 
10
 
0 
1 
1 
10
 
1 
1 
2 
11
 
0 
2 
2 
11
 
0 
1 
1 
12
 
0 
1 
1 
12
 
0 
1 
1 
13
 
0 
1 
1 
13
 
0 
0 
0 
14
 
0 
0 
0 
14
 
0 
0 
0 
15
 
0 
1 
1 
15
 
0 
2 
2 
16
 
0 
0 
0 
16
 
0 
0 
0 
17
 
0 
0 
0 
17
 
0 
0 
0 
Gr
an
d 
To
ta
l 
44
 
56
 
10
0 
To
ta
l 
30
 
29
 
59
 
  
  
  
  
Av
er
ag
e 
Ag
e 
3.
1 
3.
3 
3.
2 
Av
er
ag
e 
Ag
e 
3.
0 
3.
8 
3.
4 
 
99
Ta
bl
e 
9 
Ag
e d
ist
rib
ut
io
n o
f a
ll H
PI
V‐
1 s
am
pl
es
 co
lle
ct
ed
 of
 2n
d y
ea
r 
da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 06
/0
1/
10
‐05
/3
1/
11
 
  
Ta
bl
e 
10
 
Ag
e d
ist
rib
ut
io
n o
f a
ll H
PI
V‐
2 s
am
pl
es
 co
lle
ct
ed
 of
 2n
d y
ea
r 
da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 06
/0
1/
10
‐05
/3
1/
11
 
  
  
  
  
  
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
  
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
0 
1 
2 
3 
  
0 
1 
1 
2 
1 
0 
1 
1 
  
1 
0 
2 
2 
2 
2 
2 
4 
  
2 
4 
1 
5 
3 
0 
3 
3 
  
3 
1 
3 
4 
4 
2 
0 
2 
  
4 
2 
0 
2 
5 
0 
1 
1 
  
5 
2 
1 
3 
6 
0 
0 
0 
  
6 
2 
0 
2 
7 
0 
0 
0 
  
7 
2 
0 
2 
8 
0 
0 
0 
  
8 
0 
0 
0 
9 
1 
0 
1 
  
9 
0 
0 
0 
10
 
0 
0 
0 
  
10
 
1 
2 
3 
11
 
0 
0 
0 
  
11
 
0 
0 
0 
12
 
0 
0 
0 
  
12
 
0 
0 
0 
13
 
0 
0 
0 
  
13
 
0 
0 
0 
14
 
1 
0 
1 
  
14
 
0 
0 
0 
15
 
0 
0 
0 
  
15
 
0 
0 
0 
16
 
0 
0 
0 
  
16
 
0 
1 
1 
17
 
0 
0 
0 
  
17
 
0 
0 
0 
To
ta
l 
7 
9 
16
 
  
Gr
an
d 
To
ta
l 
15
 
11
 
26
 
  
  
  
  
  
Av
er
ag
e 
Ag
e 
5.
0 
2.
1 
3.
4 
  
Av
er
ag
e 
Ag
e 
4.
3 
4.
9 
4.
6 
 
100
Ta
bl
e 
11
 
Ag
e d
ist
rib
ut
io
n o
f a
ll H
PI
V‐
3 s
am
pl
es
 co
lle
ct
ed
 of
 2n
d y
ea
r 
da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 06
/0
1/
10
‐05
/3
1/
11
 
Ta
bl
e 
12
 
Ag
e d
ist
rib
ut
io
n o
f a
ll H
M
PV
 sa
m
pl
es
 co
lle
ct
ed
 of
 2n
d y
ea
r 
da
ta
 se
t fo
r P
EW
SS
 pr
og
ra
m
, 06
/0
1/
10
‐05
/3
1/
11
 
  
  
  
  
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
Ag
e 
Fe
m
al
e 
M
al
e 
Gr
an
d 
To
ta
l 
0 
7 
6 
13
 
0 
2 
1 
3 
1 
16
 
11
 
27
 
1 
0 
1 
1 
2 
5 
9 
14
 
2 
2 
0 
2 
3 
3 
5 
8 
3 
7 
3 
10
 
4 
2 
2 
4 
4 
0 
2 
2 
5 
1 
1 
2 
5 
0 
1 
1 
6 
1 
0 
1 
6 
2 
2 
4 
7 
0 
0 
0 
7 
0 
0 
0 
8 
0 
0 
0 
8 
2 
1 
3 
9 
2 
0 
2 
9 
0 
0 
0 
10
 
1 
0 
1 
10
 
0 
0 
0 
11
 
1 
0 
1 
11
 
0 
1 
1 
12
 
2 
0 
2 
12
 
0 
1 
1 
13
 
0 
0 
0 
13
 
0 
0 
0 
14
 
0 
1 
1 
14
 
0 
0 
0 
15
 
0 
0 
0 
15
 
0 
0 
0 
16
 
0 
0 
0 
16
 
1 
0 
1 
17
 
1 
0 
1 
17
 
0 
0 
0 
To
ta
l 
42
 
35
 
77
 
To
ta
l 
16
 
13
 
29
 
  
  
  
  
Av
er
ag
e 
Ag
e 
3.
2 
2.
0 
2.
7 
Av
er
ag
e 
Ag
e 
4.
3 
5.
1 
4.
7 
 
101
25303540
ecimens
Ad
en
ov
iru
s
05101520
Positive Sp
Da
te
CD
C P
os
iti
ve
PE
W
SS
 Po
sit
iv
es
102
80
0
10
00
12
00
14
00
101520
ve Specimens
FB Positive Specimens
Re
sp
ira
to
ry
 S
yn
cy
tia
l V
iru
s
020
0
40
0
60
0
05
CDC Positi
PEWSS and Nellis A
Da
te
PE
W
SS
 Po
sit
iv
es
N
el
lis
 Po
sit
iv
es
CD
C P
os
iti
ve
103
8101214
Specimens
Re
sp
ira
to
ry
 S
yn
cy
tia
l V
iru
s
0246
Positive 
Da
te
PE
W
SS
 Po
sit
iv
es
N
el
lis
 Po
sit
iv
es
104
8010
0
12
0
14
0
6810
Specimens
e Specimens
Hu
m
an
 P
ar
ai
nf
lu
en
za
 v
iru
s 1
0204060
024
CDC Positive 
PEWSS Positiv
Da
te
PE
W
SS
 Po
sit
iv
e
CD
C P
os
iti
ve
105
2025303540
5678910
sitives
pecimens
Hu
m
an
 P
ar
ai
nf
lu
en
za
 V
iru
s 2
05101520
012345
CDC Po
Positive S
Da
te
PE
W
SS
 Po
sit
iv
e
CD
C P
os
iti
ve
106
15
0
20
0
25
0
30
0
5678910
e Specimens
Specimens
Hu
m
an
 P
ar
ai
nf
lu
en
za
 3
05010
0
15
0
012345
CDC Positiv
Positive 
Da
te
PE
W
SS
 Po
sit
iv
e
CD
C P
os
iti
ve
107
60
00
80
00
10
00
0
12
00
0
2025303540
e Specimens
llis AFB 
imens
In
flu
en
za
 A
020
00
40
00
60
00
05101520
CDC Positiv
PEWSS and Ne
Positive Spec
Da
te
PE
W
SS
 Po
sit
iv
e
N
el
lis
 Po
sit
iv
e
CD
C P
os
iti
ve
108
15202530
pecimens
In
flu
en
za
 A
051015
Positive S
Da
te
PE
W
SS
 Po
sit
iv
e
N
el
lis
 Po
sit
iv
e
109
80
0
10
00
12
00
14
00
16
00
2025303540
e Specimens
ve Specimens
In
flu
en
za
 H
1N
1
020
0
40
0
60
0
80
0
05101520
CDC Positiv
PEWSS Positi
Da
te
PE
W
SS
 Po
sit
iv
e
CD
C P
os
iti
ve
110
20
0
25
0
30
0
1214161820
Specimens
pecimens
In
flu
en
za
 B
05010
0
15
0
0246810
CDC Positive 
Positive S
Da
te
PE
W
SS
 Po
sit
iv
e
CD
C P
os
iti
ve
111
112	
	
	References	
 
1. Armour, P. (2011). . Southern Nevada Public Health Laboratory:  
2. Bloom, B., Cohen, R., & Freeman, G. (2010). Summary health statistics for U.S. children: 
National health interview survey, 2009. National Center for Health Statistics, Vital Health 
Stat, 10, 247.  
3. Bramley, A., Bresee, J., & Finelli, L. (2009). Pediatric influenza. Pediatric Nursing, 35(6), 
335.  
4. Centers for Disease Control and Prevention. (2003).  
Sentinel Surveillance Method. Retrieved July 28, 2011, from 
http://www.cdc.gov/abcs/reports-findings/downloads/sentinel-method.pdf  
5. Centers for Disease Control and Prevention. (2010).  
2009 H1N1-related deaths, hospitalizations and cases: Details of extrapolations and 
ranges: United states, emerging infections program (EIP) data. Retrieved May 14, 2011, 
from http://www.cdc.gov/h1n1flu/pdf/Exact%20Numbers_AprilN.pdf  
6. Centers for Disease Control and Prevention. (2011). The national respiratory and enteric 
virus surveillance system. Retrieved July 28, 2011, from 
http://www.cdc.gov/surveillance/nrevss/  
7. Centers for Disease Control and Prevention. (2011). Seasonal influenza. Retrieved April 
15, 2011, from http://www.cdc.gov/flu/index.htm  
8. Copan Diagnostics Inc. Floq swabs by copan 
brochure.http://www.copanusa.com/media/brochures/FLOQSwabs_broch-w.pdf  
9. Daley, P., Castriciano, S., Chernesky, M., & Smieja, M. (2006). Comparison of flocked and 
rayon swabs for collection of respiratory epithelial cells from uninfected volunteers and 
symptomatic patients. Journal of Clinical Microbiology, DOI: 10.1128/JCM.02055-05  
10. Esper, F., Boucher, D., Weibel, C., Martinello, R., & Kahn, J. (2003). Human 
metapneumovirus infection in the united states: Clinical manifestations associated with a 
newly emerging respiratory infection in children. Pediatrics, 111(6), 1407.  
11. Falsey, A., Erdman, D., Anderson, L., & Walsh, E. (2003). Human metapneumovirus 
infections in young and elderly adults. The Journal of Infectious Diseases, 187, 785.  
12. Fleming, D., Pannell, R., & Elliot, A. (2005). Respiratory illness associated with influenza 
and respiratory syncytial virus infection. Pediatrics, 90, 741-746.  
13. Florida Department of Health. (2011). Respiratory syncytial virus surveillance. Retrieved 
April 08, 2011, from 
http://www.doh.state.fl.us/disease_ctrl/epi/rsv/Statewide_04.08.11.pdf  
113	
	
14. German, R., Lee, L., Horan, J., Milstein, R., Pertowski, C., Waller, M., et al. (2001). 
Updated guidelines for evaluating public health surveillance systems. Centers for Disease 
Control and Prevention, Morbididty and Mortality Weekly Report, 50(RR-13) Retrieved 
from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5013a1.htm  
15. Hammond, L., Papadopoulos, S., Johnson, C., MaWhinney, S., Todd, J., & Nelson, B. 
(2002). Use of an internet-based community surveillance network to predict seasonal 
communicable disease morbidity. Pediatrics, 109(3), 414.  
16. Heikkinen, T., Marttila, J., Salmi, A., & Ruuskanen, O. (2002). Nasal swab versus 
nasopharyngeal aspirate for isolation of respiratory viruses. Journal of Clinical 
Microbiology, DOI: 10.1128/JCM.40.11.4337-4339  
17. Jefferson, H., Dupuy, B., Chaudet, H., Texier, G., & Green, A. (2008). Evaluation of a 
syndromic surveillance for the early detection of outbreaks among military personnel in a 
tropical country. Journal of Public Health, 30(4), 375.  
18. Massimiliano, D., Korppi, M., Valent, F., Vainionpaa, R., & Canciani, M. (2008). Human 
metapneumovirus pneumonia in children: Results of an italian study and mini-review. 
Scandinavian Journal of Infectious Diseases, 40, 821.  
19. Milstein, R., & Wetterhall, S. (1999). Centers for Disease Control and Prevention, Morbidity 
and Mortality Weekly Report, 48(RR11) Retrieved from 
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4811a1.htm  
20. NAC: CHAPTER 441A - COMMUNICABLE DISEASES, Nevada Administrative CodeU.S.C. 
Chapter 441A (2011). Retrieved from http://www.leg.state.nv.us/NAC/NAC-441A.html  
21. NRS: CHAPTER 441A - INFECTIOUS DISEASES; TOXIC AGENTS, Nevada Revised 
StatutesU.S.C. Chapter 441A (2011). Retrieved from 
http://www.leg.state.nv.us/NRS/NRS-441A.html#NRS441ASec220  
22. Peltola, V., Ziegler, T., & Ruuskanen, O. (2003). Influenza a and b virus infections in 
children. Clinical Infectious Diseases, 36, 299.  
23. Philadelphia Department of Public Health. (2011). Seasonal influenza surveillance report. 
Retrieved February 26, 2011, from 
https://hip.phila.gov/xv/Surveillance/RespiratoryVirusSurveillance/tabid/124/Default.aspx  
24. Pleis, J., Ward, B., & Lucas, J. (2010). Summary health statistics for U.S. adults: National 
health interview survey, 2009. National Center for Health Statistics, Vital Health Stat, 10, 
249.  
25. Robinson, R. (2008). Impact of respiratory syncytial virus in the united states. American 
Journal of Health-System Pharmacy, 65, S3.  
26. Schappert, S., & Rechtsteiner, E. (2011). Ambulatory medical care utilization estimates for 
2007. National Center for Health Statistics, Vital Health Stat, 13, 169.  
27. Southern Nevada Health District. (2011). Regulations governing the reporting of diseases, 
exposures and sentinel health events. Retrieved April, 2011, from 
https://www.southernnevadahealthdistrict.org/disease-reporting/disease-regs3.php#31  
114	
	
28. State of New Jersey. (2011). Influenza surveillance system. Retrieved February 
26http://www.state.nj.us/health/flu/fluinfo.shtml#rep  
29. Walsh, P., Overmyer, C., Pham, K., Michaelson, S., Gofman, L., DeSalvia, L., et al. (2008). 
Comparison of respiratory virus detection rates for infants and toddlers by user of flocked 
swabs, saline aspirates, and saline aspirates mixed in universal transport medium for 
room temperature storage and shipping. Journal of Clinical Microbiology, DOI 
10.1128/JCM.00714-08  
30. Walton, N., Poynton, M., Gesteland, P., Maloney, C., & Staes, C. (2010). Predicting the 
start week of respiratory syncytial virus outbreaks using real time weather variables. BMC 
Medical Informatics and Decision Making, 10(68)  
31. Wilkesmann, A., Schildgen, O., Eis-Hubinger, A., Geikowski, T., Lentze, M., Bode, U., et al. 
(2006). Human metapneumovirus infections cause similar symptoms and clinical severity 
as respiratory syncytial virus infections. Europe Journal of Pediatrics, 165, 467.  
32. World Health Organization. (2009). Acute respiratory infections. Retrieved December 10, 
2010, from http://www.who.int/vaccine_research/diseases/ari/en/index2.html  
 
  
115	
	
VITA	
 
Graduate College 
University of Nevada, Las Vegas 
 
Michelle Lutman 
 
Degrees: 
Bachelor of Science, Biochemistry with an emphasis in Molecular Biology, 2006 
California Lutheran University, Thousand Oaks 
 
Thesis Title: Evaluation of the pilot program, the Pediatric Early Warning Sentinel 
Surveillance program (PEWSS), and its efficacy in monitoring pediatric illness in Clark 
County, Nevada. 
 
Thesis Examination Committee: 
Chairperson, Dr. Mark Buttner, PhD 
Committee Member, Patricia Cruz, PhD 
Committee Member, Sheniz Moonie, PhD 
Committee Member, Brian Labus, MPH 
Graduate Faculty Representative, Vernon Hodge, PhD 
